2012 aaps annual meeting and Exposition - American Association of ...

2012 awards 

prOgram 

October 14–18, 2012 

McCormick Place, Chicago

2012 aaps annual meeting and Exposition 

Sunday, October 14 

4:30 pm – 6:30 pm 

McCormick Place, Chicago 

david Y. mitchell, ph.d. 

PreSiding AAPS PreSident 

In mEmOrIum 

OpEnIng sEssIOn prOgram 

The American 

Association of 

Pharmaceutical 

Scientists (AAPS) 

is sad to report the 

loss of a dear friend 

and colleague. 

AAPS’ fourth 

president, James 

(Jim) E. Tingstad, 

passed away on 

November 9, 2011, after a long struggle with 

Alzheimer’s disease. Raised in Cook, MN, 

and Milwaukee, Tingstad served in the U.S. 

Army in Korea and attended the University 

of Wisconsin, Madison, where he received 

his doctorate in pharmaceutical sciences in 

1958. Over the course of his life, Tingstad 

You are cordially invited to 

attend the AAPS Welcome 

Reception immediately 

following this ceremony. The 

reception will take place at the 

McCormick Place Convention 

Center. Shuttle buses will be 

available to transport attendees 

to their hotels following the 

Opening Session and the 

Welcome Reception. 

held positions at various companies and 

educational institutions including 3M, Abbott 

Laboratories, and the University of California 

San Francisco School of Pharmacy. 

Tingstad’s term as AAPS president was 

characterized by growth. The association 

saw a huge increase in membership, staff 

size, and office facilities during his tenure, 

as well as the number of sections and 

growth in assets and financial security. 

Tingstad is survived by his wife Phyllis, 

four children, and a host of grandchildren, 

great-grandchildren, and other family 

and friends. AAPS remembers Tingstad 

and will forever remember his contributions 

to the association. 

2012 AAPS Annual Meeting and Exposition 1


In mEmOrIum (continued) 

dean Emeritus 

Joseph V. 

swintosky, a 

legendary educator 

and scientist 

who helped lead 

the University of 

Kentucky College 

of Pharmacy 

to national and 

international 

prominence during his tenure as dean from 

1967 to 1987, passed away on September 14, 

2012. He was 90 years old. 

Dr. Swintosky, a native of Kewaunee County, 

Wisconsin, received his bachelor of science 

degree and Ph.D. in pharmacy from the 

University of Wisconsin. An accomplished 

educator, product formulation scientist, 

and recipient of numerous national honors, 

a.J.m. (Ton) Hoek 

was born in The 

Hague, in 1955 and 

studied Pharmacy at 

the State University 

of Leiden in the 

Netherlands. 

He obtained his 

Master of Science 

degree in 1983 and 

graduated as a pharmacist in 1984. He had 

training periods in both the pharmaceutical 

practice and the hospital pharmacy. 

After university Ton Hoek joined the 

pharmaceutical industry and worked at 

several management positions both in R&D 

as well as in marketing. 

From 1999, Ton Hoek was the General 

Secretary and Chief Executive Officer of FIP, 

the International Pharmaceutical Federation. 

The FIP is the global federation of 127 

national organizations of pharmacists and 

pharmaceutical scientists, with its mission 

to improve global health by: advancing 

pharmacy practice and science, to enable 

2 

Awards Program 

Dr. Swintosky is probably best known for 

his innovative work to transform pharmacy 

education and the pharmacy profession 

while at UK. 

On January 1, 1967, Dr. Swintosky became 

the fourth Dean of the UK College of 

Pharmacy and created the master’s and 

Ph.D. graduate program, a move that 

cemented UK as a national leader in 

graduate education and pharmaceutical 

research. His impact on pharmacy 

continues today through the achievements 

of former faculty and graduates who now 

are national and international leaders, 

including at least 10 deans at other colleges. 

Dr. Swintosky was a Founder of AAPS. He 

leaves behind his wife Dorothy, nine sons 

and one daughter. 

better discovery, development, access to 

and safe use of appropriate, cost-effective, 

and quality medicines worldwide. 

Together with his counterparts from 

the World Medical Association and the 

International Council of Nurses, Hoek has 

set up the World Health Professions Alliance 

(WHPA), a strategic alliance between the 

global health professional associations 

representing physicians, nurses, dentists 

and pharmacists. 

In 2012 Hoek was awarded an Officer in 

the Orange-Nassau, a Royal declaration 

bestowed by the Queen of the Netherlands. 

During the awards ceremony for this 

prestigious designation he was also 

recognised with an honorary resolution 

from the American Pharmacists Association 

(APhA) citing his active dedication to 

pharmacy and a joint congratulatory letter 

from the APhA, the American Association 

of Colleges of Pharmacy (AACP), the 

American Association of Pharmaceutical 

Scientists (AAPS) and the American Society 

of Health-Systems Pharmacists (ASHP).

aaps 2012 ExEcuTIVE cOuncIl 


PreSident 

philip r. mayer, ph.d. 

iMMediAte PASt PreSident 

anthony J. destefano, ph.d. 

PreSident-eleCt 

wayne r. gombotz, ph.d. 

treASurer 

marilyn E. morris, ph.d. (2012) 

MeMber-At-lArge 

James E. polli, ph.d. (2013) 


raman Venkataramanan, ph.d. (2013) 


dannette K. doolittle, ph.d. (2014) 


russell s. weiner, ph.d. (2014) 




wElcOmIng rEmarKs 

John lisack, Jr., caE 

exeCutive direCtOr 

4 



AAPS PreSident 

prEsEnTaTIOn and rEcOgnITIOn Of all awards 

david Y. mitchell, ph.d. leslie Z. Benet, ph.d. 

AAPS PreSident univerSity Of CAlifOrniA

spEcIal rEcOgnITIOns 

IpEc Excipient graduate 

student awards 

xi Han 

new JerSey inStitute Of teChnOlOgy 

grace Ilevbare 

Purdue univerSity 

sumit Kumar 

univerSity Of COnneCtiCut 

Ting wang 

univerSity Of MArylAnd, bAltiMOre 

amit wani 

wAyne StAte univerSity 

phrma pre doctoral fellowships 

in the pharmaceutics 

sweta modi 

univerSity Of KentuCKy 

poonam sheth 

univerSity Of ArizOnA 

matthew Herpin 

univerSity Of texAS At AuStin 

phrma research starter grants 

in pharmaceutics 

Oleh Taratula, ph.d. 

OregOn StAte univerSity 

afpE minority pre-doctoral fellows 

in pharmaceutical science 

sophia n. Ononye 


award rEcIpIEnTs 

aaps-afpE pre-doctoral fellows 

in the pharmaceutical sciences 

Vaishali l. chudasama 

univerSity At buffAlO, Suny 

caroline a. larregieu 

univerSity Of CAlifOrniA, SAn frAnCiSCO 

afpE pre-doctoral fellows in clinical 

pharmaceutical sciences 

daniel J. crona 

univerSity Of nOrth CArOlinA 

melanie r. nicol 

univerSity Of nOrth CArOlinA 

aaps graduate student symposium 

in analysis & pharmaceutical Quality 

SPOnSOred by u.S. Pharmacopeia 

and wolfe labs 

McCormick Place Convention Center 

room w190A 

tuesday, October 16, 2012 

8:30 am – 11:00 am 

cary mcginnis 

univerSity Of geOrgiA 

Quantification and Characterization 

of siRNA and its Metabolites in 

Biological Matrices 


award recipients 

Khushboo Bakul Kothari 

univerSity Of MinneSOtA 

Investigating the Role of Polymer 

Concentration on the Physical Stability of 

Nifedipine-PVP Solid Dispersions 

lindsay anne wegiel 


Assessment of Molecular Drug-polymer 

Interactions by Mid-infrared Spectroscopy 

as a Polymer Selection Tool for Formulating 

Amorphous Solid Dispersions with Optimal 

Physical Stability 

poonam r. delvadia 

virginiA COMMOnweAlth univerSity 

High Performance Liquid Chromatographic 

Method and Selectivity Investigation for the 

Analysis of Nicotine in Biorelevant Release/ 

Permeation Studies of Smokeless Tobacco 

6 



in Biotechnology 

SPOnSOred by Pfizer global research 

and development 


room w190b 


8:30 am – 11:00 am 

david woessner 

univerSity Of utAh 

Synthetically Lethal Combinations for CML 

Therapy—Disrupting Dimerization of Bcr-Abl 

and Secondary Leukemia Specific Pathways 

Jin Huk choi 

the univerSity Of texAS At AuStin 

Modeling Pre-existing Immunity to 

Adenovirus as a Method to Identify Novel 

Formulations for a Protective Ebola Vaccine 

mamta Kapoor 


Elucidation of Cellular Uptake Mechanism of 

Novel Ternary Anionic-siRNA Lipoplexes

puneet Tyagi 

univerSity Of COlOrAdO 

A Highly Potent, Choroid-targeted, 

Transferrin-tumstatin Fusion Protein 

and an In Situ Forming Slow-release 

Hydrogel for the Treatment of Choroidal 

Neovascularization 


in drug discovery and development 

Interface 

SPOnSOred by Allergan, wolfe laboratories, 

and bristol-Myers Squibb Company 


room w185 


8:30 am – 11:00 am 

Yumna shabaik 

univerSity Of SOuthern CAlifOrniA 

Mechanistic Evaluation of a Mitochondrialtargeted 

Small Molecule as a Novel 

Treatment for Pancreatic Cancer 

sashikanth Banappagari 

the univerSity Of lOuiSiAnA At MOnrOe 

Modulation of EGF-receptors Signaling by 

Small Peptidomimetics and its Implications in 

Breast Cancer Progression 


lu xu 

univerSity Of the PACifiC 

Molecular Docking, Synthesis of Novel 

Quinazolin Analogues as Inhibitors of 

Transcription Factors NF-kappaB Activation 

and their Anti-cancer Activities 

lakshmi prasanna Kolluru 

MerCer univerSity 

Design and Development of Albumin Based 

Theragnostic Nanoparticles for Tumor 

Targeted Drug Delivery 

aaps graduate student symposium in 

formulation design and development 

SPOnSOred by bristol-Myers 

Squibb Company 


room w196 


8:30 am – 12:00 pm 

apurva r. patel 

flOridA A&M univerSity 

Theranostic Tumor Homing Pegylated 

Nanocarrier Drug Delivery System for 

Treatment of Cancer 



grace a. Ilevbare 


Understanding Polymer Properties Important 

for Crystal Growth Inhibition—Impact of 

Chemically Diverse Polymers on Solution 

Crystal Growth of Ritonavir 

Jiban Jyoti panda 

f.M. univerSity, OriSSA, indiA 

Self-assembled Dipeptide Nanotubes, 

Nanovesicles and Nanogels: Potential 

Vehicles for Targeted Tumor Drug Delivery 


manufacturing science and Engineering 




room w196 


8:30 am – 12:00 pm 

Ekneet Kaur sahni 


Contact Drying in an Agitated Filter-Dryer: 

Experiments and Simulations 

8 



in physical pharmacy and 

Biopharmaceutics 




room w196 


8:30 am – 12:00 pm 

caleb Brian 

univerSity Of wiSCOnSin, MAdiSOn 

Surface Diffusion of the Organic 

Glass Nifedipine 

sunny Bhardwaj 


Molecular Mobility as an Effective Predictor 

of the Physical Stability of Amorphous State 


pharmacokinetics, pharmacodynamics, 

and drug metabolism and clinical 

pharmacology and Translational 

research 

SPOnSOred by eli lilly and Company 


room w184 


8:30 am – 12:00 pm

ajendra s. Kadam 

univerSity Of COlOrAdO 

Expression and Activity of Drug Transporters 

in Human Ocular Barriers and Disease 

Related Changes: Implications for 

Transporter Guided Retinal Drug Delivery 

nimita dave 

univerSity Of CinCinnAti 

Brain/Brain Tumor Pharmacokinetics and 

Pharmacodynamics of Letrozole 

rachel J. Eclov 

univerSity Of CAlifOrniA, SAn frAnCiSCO 

In Vivo Characterization of ABCG2 Enhancers 

Bridget morse 


Effect of Monocarboxylate Transporter 

Inhibition on the Oral Toxicokinetics/ 

Toxicodynamics of γ-hydroxybutyrate (GHB) 

and γ-butyrolactone (GBL) 


ramola sane 


Application of a Novel Microemulsion 

Formulation of Elacridar to Improve Drug 

Distribution into the Brain for Therapy of 

Glioblastoma 

Hoi Kei lon 


Modeling Effects of Dexamethasone on 

Disease Progression of Bone Mineral Density 

in Collagen-induced Arthritic Rats 

aaps Outstanding graduate student 

research award in pharmaceutical 

Technologies 

SPOnSOred by Covidien 

Qi (Tony) Zhou 

MOnASh univerSity, AuStrAliA 

Effect of Surface Coating with Magnesium 

Stearate via Mechanical Dry Powder 

Coating Approach on the Aerosol 

Performance of Micronized Drug Powders 

from Dry Powder Inhalers 



mentor: david a V morton, ph.d. 


aaps lipid-based drug delivery 

graduate student award 

SPOnSOred by gattefossé Corporation 


room w186 

Monday, October 15, 2012 

12:15 pm – 1:15 pm 

Yan Yan Yeap 


aaps graduate student award 

in Quality by design and product 

performance 

SPOnSOred by Quality by design and 

Product Performance focus group 


room w178 


4:30 pm – 5:30 pm 

rishi Kapil 

PAnJAb univerSity (uiPS), indiA 

10 


aaps Ocular drug delivery & 

disposition focus group graduate 

student poster award 

SPOnSOred by bausch and lomb 


room w185 


12:15 pm – 1:15 pm 

megha Barot 

univerSity Of MiSSOuri, KAnSAS City 

aaps postdoctoral fellow award 

SPOnSOred by Abbott laboratories 

and Merck 

The AAPS Postdoctoral Fellow Award 

is given annually to individuals who 

demonstrated excellence in his/her research 

work during a postdoctoral training period 

and shows exceptional promise in future 

contributions to pharmaceutical sciences. 

courtney sloan, ph.d. 

univerSity Of illinOiS At urbAnA-ChAMPAign 

Dr. Sloan received her Ph.D. in 

Pharmaceutical Chemistry from the 

University of Kansas under the guidance of 

Dr. Susan Lunte in 2011. While in graduate 

school, Dr. Sloan developed analytical 

methods for characterizing the metabolism 

of neuropeptides involved in pain signaling, 

neurotoxicity, and addiction. Additionally, 

she investigated the transport of peptide 

metabolites at the blood-brain barrier. 

utilizing bovine brain microvessel endothelial 

cells. Currently at the University of Illinois at

Urbana-Champaign (UIUC) she is working 

in Dr. Ryan Bailey’s group in a collaborative 

effort with Dr. Stephen Sligar’s group, 

also at UIUC. Professor Bailey’s group has 

extensively developed silicon photonics as 

an analytical tool to investigate molecular 

binding events and kinetics with soluble 

biomolecules such as DNA and antibodies. 

Dr. Sloan is demonstrating the utility of the 

optical microring resonator platform for 

studying interactions between membranebound 

proteins and soluble ligands, 

utilizing nanodiscs to solubilize membrane 

proteins and maintain their structure in a 

native-like lipid bilayer. Microrings provide 

a highly multiplexed analysis platform 

for characterizing these receptor-ligand 

interactions. Dr. Sloan hopes to develop 

the platform to investigate the role of G 

protein coupled receptors (GPCRs) as 

pharmaceutical targets and monitor G 

protein coupling as indicators for potential 

off-target drug effects. 

sumith a. Kulartne, ph.d. 

the SCriPPS reSeArCh inStitute 

Dr. Kulartne is the Vice President of 

Research & Development, On Target 

Laboratories, LLC, West Lafayette, IN (March 

2012– present). Under his guidance, On 

Target is developing targeted-Near Infra 

Red (NIR) imaging agents that detect 

tumor margins during surgery for cancers 

and biologics for inflammatory diseases. 

On Target is conducting multiple clinical 

trials at Mayo clinics, UPenn, IU Medical 

School for cancers such as ovarian, lung, 

prostate, and kidney. Dr. Kularatne pursued 

his postdoctoral studies in biomedicines 

to target metastatic cancers, cancer stem 

cells, acute myeloid leukemia, and ovarian 

cancer using anti-CXCR4, IL3, and bispecific 

antibodies with Dr. Peter G. Schultz, The 

Scripps Research Institute, La Jolla, CA 

(Dec 2009–Feb 2012). He earned his 


Ph.D. in organic/medicinal chemistry from 

Purdue University (Dec 2005-Dec 2009), 

conducting research under the guidance 

of Ralph C. Corley Distinguished Professor 

Philip S. Low. During his doctoral studies, 

Dr. Kularatne has developed PSMA-targeted 

SPECT, PET, and optical imaging and 

therapeutic agents for prostate cancer. 

He has also developed folate receptortargeted 

PET imaging and therapeutic. 

PSMA-targeted SPECT imaging agent that 

he developed is currently evaluating in 

Phase I clinical trials at IU Medical School 

and PSMA-targeted therapeutic agents are 

under clinical development at Endocyte Inc, 

West Lafayette, IN. 

Innovation in nanotechnology award 

SPOnSOred by hospira 


room w190b 


4:30 pm – 5:30 pm 

This award is intended to recognize and 

promote the achievement of an individual 

that demonstrates innovation in the area 

of nanotechnology as applied to drug and 

device development. 

arun Kumar upadhyay, ph.d. 

univerSity Of COlOrAdO AnSChutz 

MediCAl CAMPuS 

Dr. Upadhyay has developed protein, 

polymer, and virus based nanosystems 

for enhanced and/or sustained delivery of 

therapeutic agents including small molecule 

drugs, peptides, and proteins. He also 

elucidated the mechanisms of inclusion 

body formation and developed approaches 

for efficient purification of protein drugs. 

His long term goals include development of 

new drugs and delivery systems for treating 

retinal degenerative diseases. 



Outstanding Educator award 

SPOnSOred by biogen idec 

The AAPS Outstanding Educator Award 

recognizes excellence in education in the 

technologies related to pharmaceuticals. 

John l. neumeyer, ph.d. 

hArvArd MediCAl SChOOl/MCleAn hOSPitAl/ 

AdArC 

Dr. Neumeyer, Matthews Distinguished 

Professor of Medicinal Chemistry (Emeritus) 

at Northeastern University, has been 

designing and synthesizing molecules for 

mapping and studying dopamine receptors 

in the brain. Parkinson’s disease (PD) is 

caused by the degeneration of a set of 

neurons in the brain that use dopamine as a 

neurotransmitter. By modifying the structure 

of apomorphine, a dopamine receptor 

agonist, and related aporphines, chemists, 

pharmacologists and molecular biologists 

could infer the 3D arrangement of amino 

acids at the dopamine-binding site. On the 

other hand, chemical analogs related to 

cocaine as well as cocaine itself, are known 

to inhibit dopamine uptake by binding to 

cocaine receptor sites. Thus, suitably labeled 

cocaine analogs could be used as probes to 

investigate the neurochemical mechanism 

of Parkinson’s disease and other disorders 

involving dopamine neurotransmitters. 

This type of thinking led Neumeyer and his 

co-workers to synthesize a new radiotracer 

[¬123I]-¬¬CIT. This tracer can be used 

in single-photon emission computed 

tomography (SPECT) imaging to pinpoint 

sites where dopamine is taken up. Similarly, 

the imaging technique known as positron 

emission tomography (PET) requires 

positron-emitting nuclides such as 18F or 11C. 

The radiotracer [¬123I]-FP¬CIT (ioflupane, 

DATscan ® ) is now a commercially available 

imaging agent used for the early diagnosis 

of PD or to monitor the progression of PD 

in patients. 

12 


Dr. Neumeyer has trained over 60 graduate 

students and post-doctoral fellows in the 

pharmaceutical sciences at Northeastern 

University and continues to train postdoctoral 

fellows as Director of the Medicinal 

Chemistry Program at McLean Hospital, 

Harvard Medical School. 

new Investigator grant in 

pharmaceutics and the 

pharmaceutical Technologies 

SPOnSOred by Pfizer global research 

and development 

The AAPS New Investigator Grant in 

Pharmaceutics and the Pharmaceutical 

Technologies is a one-time grant of $25,000 

to be used to support the research efforts 

of an individual actively engaged in training 

graduate students and carrying out the basic 

research in pharmaceutics, drug delivery 

and/or the pharmaceutical technologies. 

seungpyo Hong, ph.d. 

univerSity Of illinOiS At ChiCAgO 

Dr. Hong is Assistant Professor in the 

Department of Biopharmaceutical Sciences 

at the University of Illinois at Chicago. He 

received his B.S. and M.S. degrees from 

Polymer Engineering at Hanyang University, 

Seoul, Korea in 1999 and 2011, respectively. 

In 2006, he graduated with his Ph.D. in 

Macromolecular Science and Engineering at 

the University of Michigan (advisors: Profs. 

Mark Banaszak Holl and James Baker, Jr.) 

before he joined Prof. Robert Langer’s lab 

at MIT for his postdoctoral training. Since 

2008, he has established an independent 

research program under the overall theme 

of “Biomimetic Nanotechnology”, focusing 

on three major areas: 1) Nanocarrier systems 

for targeted delivery of therapeutics 

using biomimetic approaches; 2) Topical, 

transdermal delivery systems for breast 

cancer prevention using nanoparticle-drug

combinations; and 3) Biomimetic microfluidic 

chips for effective separation of circulating 

tumor cells. He has published over 35 peerreviewed 

articles that have been cited a 

combined total of over 2,200 times, three 

book chapters, and nine patents (pending or 

awarded) while presenting 33 invited talks 

and over 80 conference proceedings. 

aaps community service award 

SPOnSOred by the university of Colorado/ 

Center for Pharmaceutical biotechnology 

The AAPS Community Service Award is 

intended to recognize an AAPS member 

for the personal effort that he/she created 

and managed, preferably as a volunteer and 

not part of duties in a paid position, for a 

sustained community service effort. 

Joseph w. polli, ph.d. 

glAxOSMithKline, inC. 

Dr. Joseph Polli received the AAPS 

Community Service Award for service to Cub 

Scout Pack 152, Boy Scout Troop 152 and 

the Crosswinds District of the Boys Scouts 

of America located in Cary, North Carolina. 

Over the past 14 years, he has contributed 

to the skills and leadership development 

of more than one hundred young men, 

provided organizational leadership to the 

BSA, developed the high adventure outdoor 

camping program, and has donated financial 

support. One highlight of Dr. Polli’s service 

includes founding and chartering Troop 152 

with 6 scouts in 2003. Twenty-five scouts 

have since obtained the rank of Eagle. Dr. 

Polli has held multiple leadership positions, 

including being the founding Committee 

Chair of Troop 152, Charter Organizational 

Representative, Assistant Scoutmaster, 

Secretary/Treasurer and District Eagle 

Board of Review Member. In addition, Joe 

is an avid camper who challenges scouts 

to go beyond what they believe they are 

capable of achieving. Outside of scouting, 


Dr. Polli is an internationally recognized 

researcher in membrane transporters and 

drug development. His main research 

interests include membrane transporters that 

influence drug disposition, prediction of drug 

interactions, and processes to enhance the 

development of drug candidates. 

The IpEc foundation ralph shangraw 

memorial award 

The Ralph Shangraw Memorial Award is 

to be awarded to any person who has 

provided outstanding research contributions 

in the study of excipients or excipientrelated 

technology over a number of years, 

including an understanding of the basic 

science underlying excipient functionality 

and the development of new excipients or 

noveluse of existing excipients. 

Hans E. Junginger, ph.d. (retired) 

MArbury, gerMAny 

Professor Junginger received his Ph.D. at 

the University of Saarland (Germany) in 1971. 

He was a Professor of pharmaceutics and 

the Head of the Division of Pharmaceutical 

Technology at the Leiden/Amsterdam Center 

for Drug Research, Leiden University, The 

Netherlands, until February 1, 2004 when he 

went with early retirement. His main research 

areas include the development of novelcontrolled 

drug delivery systems peroral 

routes, utilizing new (bioadhesive) polymers 

for the nasal, pulmonary and oral route for 

peptides, proteins, and (DNA) vaccines. 

He also was strongly involved in (trans) 

dermal drug research and has developed 

more than 100 cosmetics products based 

on aloe vera. He has received several major 

awards including the American Association of 

Pharmaceutical Scientists (AAPS) Dr. Rainer 

Hoffman Product through Science Award, and 

three honorary doctorates (Gent, Belgium, in 

1995, Potchefstroom University in South Africa 

in 2003, and London University, UK in 2004). 



The IpEc foundation Industry 

research achievement in Excipient 

Technology award 

The Industry Research Achievement in 

Excipient Technology Award is to recognize 

individuals working in an industrial setting 

who have made significant contributions in 

the filed of excipient technology. 

Brian a c carlin, ph.d. 

fMC biOPOlyMer 

Professor Brian Carlin is Director of Open 

Innovation (Pharma), at FMC BioPolymer. 

He was previously the Global Mgr 

Pharmaceutical R&D and has been with FMC 

for seventeen years. Professor Carlin chairs 

the IPEC Americas Quality by Design and 

Excipient Composition Committees and also 

serves on the USP Excipient Committee. 

Prior to joining FMC Professor Carlin 

worked at SmithKline & French/SmithKline 

Beecham in new product development 

for eleven years. He started in the industry 

with Richardson Vicks, working for five 

years in commercial product development. 

He obtained his doctorate in Interfacial 

Rheology from the School of Pharmacy, 

University of London, and an Honours 

degree in Pharmacy from the University 

of Aston in Birmingham. He serves on the 

distance learning MSc course at Demontfort 

University, UK, where he is an honorary 

visiting Professor. Professor Carlin has been 

a leading advocate for innovative scientific 

approaches to excipients and pharmaceutics 

in pursuit of the QbD vision of the 21st 

century cGMP initiative. 

14 


Outstanding manuscript award in 

analysis and pharmaceutical Quality 

SPOnSOred by Celgene 

The AAPS Outstanding Manuscript Award 

in Analysis and Pharmaceutical Quality 

is intended to recognize outstanding 

achievement in Pharmaceutical Analysis 

and Quality as demonstrated by author(s) 

in a manuscript published in an analytically 

focused journal. 

raj suryanarayanan, ph.d. 


Kapildev K. arora, ph.d. 


nitin g. Tayade, ph.d. 

univerSity Of MinneSOtA

Outstanding manuscript award in 

modeling and simulation 

SPOnSOred by Projections research 

The AAPS Outstanding Manuscript in 

Modeling and Simulation Award is intended 

to recognize outstanding achievement 

in modeling and simulation in clinical 

pharmacology and translational research as 

demonstrated by the author in the quality 

and originality of a manuscript published in 

any peer-reviewed journal. 

paulo paixão, ph.d. 

univerSity Of liSbOn, POrtugAl 

José a.g. morais, ph.d. 


luís f. gouveia, ph.d. 



Pharmaceutical Research meritorious 

manuscript award 

SPOnSOred by Pfizer inc. 

The AAPS Pharmaceutical Research 

Meritorious Manuscript Award recognizes 

outstanding achievement in the 

pharmaceutical sciences as demonstrated 

by the author in the quality and originality of 

a manuscript published in the official AAPS 

journal, Pharmaceutical Research. 

Understanding the Behavior of Amorphous 

Pharmaceutical Systems during Dissolution 

Pharmaceutical Research, 27, Number 4 

(2010), DOI: 10.1007/s11095-009-0021-1 

lynne s. Taylor, ph.d. david E. alonzo, ph.d. 

Purdue univerSity AbbOtt lAbOrAtOrieS 

deliang Zhou, ph.d. Yi gao, ph.d. 

AbbOtt lAbOrAtOrieS AbbOtt lAbOrAtOrieS 

geoff g.Z. Zhang, ph.d. 

AbbOtt lAbOrAtOrieS 


aaps fEllOws 

aaps fellows 

AAPS confers the honor of Fellow to recognize individuals for outstanding contributions, 

which elevate the stature of the pharmaceutical sciences, and for professional excellence 

in the field relevant to the mission of AAPS. The primary criterion for selection as an AAPS 

Fellow is professional competence reflected through scholarly and research contributions 

to the pharmaceutical sciences such as original articles, scientific presentations at annual 

meetings, and/or patents. 

Okezie I. aruoma, m.B.a., d. sc., ph.d. 

AMeriCAn univerSity Of heAlth SCienCeS 

Dr. Aruoma has developed an internationally 

recognized program in translational 

sciences research with direction focused 

on the understanding the bioefficacy of 

functional nutraceuticals derived from fruits, 

vegetables and medicinal plants and how 

these may potentially prevent or reverse 

the promotion or progression of the chronic 

diseases with overt inflammation (such 

as diabetes, cancers, rheumatoid arthritis, 

Parkinson’s and Alzheimer’s). The associated 

cognitive functions impairment, movement, 

psychopathological and behavioral disorders 

significantly decreases the quality of life. Dr 

Aruoma’s research team assessed the effect 

of black tea on risk factors of cardiovascular 

disease in patients with diabetes and 

in normal population at risk of diabetes 

and found that black tea consumption 

reduces uric acid and C-reactive protein 

levels and decreased the LDL/HDL ratio, 

an outcome that may benefit humans 

at high risk of cardiovascular events and 

may augment prescription drug therapy. 

The long term objectives of Dr Aruoma’s 

research is enshrined in the context of 

the search for functional nutraceuticals 

as neuroprotectants, cardioprotectants 

and cognitive enhancers with proven 

bioefficacy that not only meet the public 

health concerns but can be responsive to a 

comprehensive portfolio of biomarkers that 

can benefit testing for the complications of 

diabetes and neurodegenerative diseases. 

16 


alekha K. dash, r.ph., ph.d. 

CreightOn univerSity 

Dr. Alekha K. Dash received his bachelor’s 

and master’s degrees in Pharmacy from 

Jadavpur University, India, and a Ph.D. 

from the University of Minnesota. He is 

professor and chair of the Department of 

Pharmacy Sciences, Creighton University, 

and holds the Gilbert F. Taffe Jr. Endowed 

Chair of Pharmacy. Dr. Dash’s research 

interests include design and evaluation of 

novel drug delivery systems, preformulation 

studies, solid-state pharmaceutics, and 

pharmaceutical analysis. Dr. Dash has made 

unique and outstanding contributions to 

numerous facets of pharmaceutical analysis. 

In light of his interest in drug delivery, 

the analytical methods developed were 

applied to the fabrication and evaluation of 

novel drug delivery systems. In situ gel for 

sustained drug delivery and targeting, solidlipid 

nanoparticles for tumor localization, and 

nanoparticulate delivery for HIV treatment 

are few examples. He has received several 

awards for teaching, research, and service. 

Dr. Dash has more than 50 peer reviewed 

publications, 120 poster and podium 

presentations, and several approved patents. 

He is a member of six professional societies, 

serves on numerous editorial boards, and 

is a reviewer for 20 peer-reviewed journals. 

He has authored chapters in a number of 

texts, and has been an invited speaker at the 

international, national, and local levels.

melgardt m. de Villiers, B. pharm., ph.d. 

univerSity Of wiSCOnSin – MAdiSOn 

Dr. de Villiers of the University of Wisconsin, 

has developed an internationally recognized 

research program in the application 

of thin coatings to improve the solidstate 

properties of drugs and excipients. 

This program has revolved around the 

application of layer-by-layer self-assembled 

nanocoatings on pharmaceutically 

important surfaces. His group was the first 

to apply this technology to create slow 

release nanoparticles (furosemide and 

dexamethasone), protective nanoshells 

(photo-protection of light sensitive drugs) 

around drug particles and to produce 

improved excipients (directly compressible 

lignocellulose). Dr. de Villiers is also an 

adjunct-professor in the School of Pharmacy 

at North-West University, South Africa. 

With his colleagues from South Africa their 

work on the quality of drug and excipient 

raw materials has made several important 

contributions. For example, this work has 

led to several publications highlighting the 

importance of recognizing that polymorph 

identification plays a role in the quality of 

generic drugs. His work on the effect of 

mebendazole has led to a change in The 

International Pharmacopoeia (4th Edition 

of the International Pharmacopoeia, WHO). 

This monograph now clearly states “… 

Mebendazole exhibits polymorphism. The 

polymorph specified in the monograph 

(form C) corresponds to the crystal form of 

mebendazole RS.” 


glen s. Kwon, ph.d. 

univerSity Of wiSCOnSin – MAdiSOn 

Dr. Kwon is a professor and holder of the 

inaugural Jens T. Carstensen Distinguished 

Chair in the School of Pharmacy at the 

University of Wisconsin. His research 

program focuses on polymeric assemblies 

for drug delivery, non-viral gene delivery 

and optical imaging. In this context, his 

interests in pharmaceutical research include 

drug solubilization, controlled release 

and tumor targeting. His research team 

has extensively studied amphiphilic block 

copolymer (ABC) micelles as nanoscopic 

supramolecular core/shell structures for 

drug delivery. The design and chemistry 

of ABC micelles has addressed drug 

loading for drug solubilization, safety for 

intravenous injection, pharmacokinetics and 

extracellular or intracellular drug release. He 

has pioneered multiple drug solubilization 

by ABC micelles using physical interactions 

and chemical pro-drug strategies. In the 

former case, simple changes in side chains 

of a core-forming block have been used to 

tune drug loading and release. In the latter 

case, drug release depends on pH, providing 

a strategy for triggered multi-drug release 

in endosomes/lysosomes of cancer cells. Dr. 

Kwon participates in collaborative research 

on multi-modal therapeutic strategies that 

involve hybrid nanomedicines that are 

bio-responsive, synergistic and theranostic, 

aiming for progress against lung, breast and 

ovarian cancers and life-threatening systemic 

fungal diseases. 



Tarun K. mandal, m. pharm., ph.d. 

xAvier univerSity Of lOuiSiAnA 

Dr. Mandal is an Endowed Professor of 

Pharmacy at Xavier University of Louisiana. 

He has been recognized for his outstanding 

contributions in the area of novel and 

innovative drug delivery. His research 

focuses on the design and development of 

commercially viable formulations to improve 

the safety, efficacy, and patient compliance. 

Cutting-edge research in his laboratory has 

resulted in controlled release formulations 

of many therapeutic agents. The 

microencapsulation techniques developed 

in his lab have resulted in effective control 

release formulations for large and small 

molecules with varying water solubility. His 

group has developed a film coating process 

that permits a less complex application of 

multiple coats on a substrate to control the 

release of active ingredients. Working in 

the area of Nanotechnology, his group has 

developed orally active nanoparticles to 

treat radiation injury. The use of siRNA for 

the treatment of life threatening diseases 

like cancer and infectious diseases is another 

area of interest of his group. His group has 

developed a novel lipid based non-toxic 

siRNA-nanoparticle for the treatment of 

Hepatitis C. He has published close to 200 

original research paper, review, abstracts, 

and monographs and filed four patents. 

18 


mehul u. mehta, ph.d. 

u.S. fOOd And drug AdMiniStrAtiOn 

Dr. Mehta has been the Director of Division 

of Clinical Pharmacology (CP) I in CDER, 

FDA for the last 14 years. During this 

period, he has worked tirelessly to bring 

out regulatory guidances in the areas of 

Biopharmaceutics and CP with the intent to 

avoid unnecessary human bioequivalence 

studies, based on robust science, and to 

guide drug development by defining best 

practices in CP. Thus, under his leadership, 

the Agency issued two guidances with 

significant and positive impact. The first 

one, “SUPAC – MR” guidance provided 

regulatory relief to the manufacturers of 

modified release products when faced 

with scale-up and post-approval changes, 

based on judicious in-vitro and in-vivo 

tests. The second guidance, “PK in Hepatic 

Impairment”, standardized the conduct and 

assessment of pharmacokinetic studies in 

hepatic impairment for all new drugs and 

has played a pivotal part in proper dosing 

recommendations in this important patient 

population for hundreds of new drugs. Dr. 

Mehta is also a leading Agency scientist on 

the Biopharmaceutics Classification System 

(BCS) and has been the co-chair of the 

CDER BCS Committee for last 8 years where 

he has helped the Agency implement the 

BCS guidance and granting of BCS based 

biowaivers for nearly 100 drug products.

michael a. repka, d.d.s., ph.d. 

univerSity Of MiSSiSSiPPi 

Dr. Michael A. Repka’s most important 

scientific accomplishments involve the 

advancement of hot melt extrusion (HME) 

technology. He has established himself 

as an expert in this major pharmaceutical 

processing field, through his numerous 

peer-reviewed publications, presentations 

and scientific talks. Polymeric drug delivery 

design and stabilization, formulation and 

process development for natural products, 

antifungal/antibacterial agents and 

vaccines, are important components of his 

research. He has contributed significantly 

to several drug delivery areas including 

oral, transdermal/trans-nail, nose-to-brain, 

and transcorneal delivery. Dr. Repka is 

Chair and Professor of the Department 

of Pharmaceutics and Director of the Pii 

Center for Pharmaceutical Technology at 

The University of Mississippi. He joined 

The University of Mississippi faculty after 

receiving his Ph.D. from The University 

of Texas, College of Pharmacy, and also 

founded a pharmaceutical research/ 

development company specializing in drug 

delivery. Dr. Repka serves on the Editorial 

Advisory Boards of six prestigious journals, 

is Associate Editor for AAPS PharmSciTech 

and Editor for North America for Journal 

of Drug Delivery Science and Technology. 

He served as Chair of the Modified Release 

Focus Group (2011) and was subsequently 

elected Vice Chair of the Formulation Design 

and Development Section within AAPS. 

Dr. Repka regularly speaks at international 

HME symposia and workshops. 


lynne s. Taylor, ph.d. 


Dr. Taylor is well known for her research 

program in the area of the solid-state phase 

behavior of pharmaceutical materials. In 

particular, she has addressed the phase 

behavior of high energy solids such as 

amorphous forms, which are of interest 

for the delivery of poorly water soluble 

compounds. Much of her research in the 

area has revolved around the exploration of 

polymers to inhibit crystallization of the drug 

from the formulation and the supersaturated 

solution generated upon dissolution of 

the enabling formulation. Other important 

areas of research include addressing the 

role of water-solid interactions in promoting 

chemical and physical instabilities, as well 

as the investigation and application of 

advanced analytical techniques for solidstate 

characterization. The long term 

goal of Dr. Taylor’s research is to gain 

a comprehensive understanding of the 

interplay between solid-state properties 

and drug performance in vivo. 



Timothy s. Tracy, ph.d. 


Dr. Tracy has developed an internationally 

recognized program in the area of 

human drug metabolism and disposition, 

centering on the role of cytochrome P450 

drug metabolizing enzymes, specifically 

CYP2C9. This has involved examination 

of the structure-function relationship of 

CYP2C9 resulting in some of the seminal 

work on the conformational plasticity of 

the P450 enzymes leading to a better 

understanding of not only their broad 

substrate specificity but also atypical 

enzyme kinetics. The work has expanded 

to examine the role in pharmacogenetics of 

CYP2C9 in altering substrate metabolism 

and how pharmacogenetics can impact 

drug-drug interactions. Work from his 

laboratory has demonstrated that reduced 

activity allelic variants of CYP2C9 can 

significantly attenuate drug-drug interaction 

potential in humans and necessitate 

differential alterations in drug dose based 

on an individual’s genotype in cases where 

interacting drugs must be co-administered. 

More recently, this research has examined 

the role of protein-protein interactions 

among the cytochrome P450 enzymes 

and how these interactions may alter 

drug metabolism capacity. The long term 

objective of Dr. Tracy’s research is to develop 

predictive models of in vivo human drug 

metabolism and drug-drug interactions from 

in vitro data to improve therapeutic efficacy 

and minimize toxicity. 

20 


Jeffry g. weers, ph.d. 

nOvArtiS PhArMACeutiCAl COrPOrAtiOn 

Evans and Wennerström noted that the 

colloidal domain is where biology, chemistry, 

physics, and technology meet. Nowhere is 

this more important than in the field of drug 

delivery. Dr. Weers’ career has focused on 

the development of engineered particles 

for biomedical and consumer products. 

He is an inventor of 40 patents with an 

additional 45 published patents pending. 

Among his inventions are a blood substitute 

formulation based on nanoemulsion droplets 

of perfluorooctyl bromide (Oxygent), 

and an ultrasound contrast agent based 

on microbubbles of perfluorohexane 

(Imagent®). More recently, his research has 

focused on finding better ways to deliver 

drugs via inhalation. In this regard, Dr. Weers 

designed aerosol formulations comprising 

hollow porous particles (PulmoSphere 

technology) for use in portable inhalers. 

The PulmoSphere technology was utilized 

in the development of the TOBI ® Podhaler, 

a dry powder formulation of tobramycin 

for the treatment of chronic Pseudomonas 

aeruginosa infections in cystic 

fibrosis patients.

spEcIal 

rEcOgnITIOns 

philip r. mayer, ph.d. 

AAPS PASt PreSident 

wayne r. gombotz, ph.d. 

AAPS treASurer 

marilyn E. morris, ph.d. 

AAPS MeMber-At-lArge 

spEcIal rEcOgnITIOns 

rEpOrT Of 

THE prEsIdEnT 


AAPS PreSident 



aaps research achievement awards 

The AAPS Research Achievement Awards are intended to recognize outstanding scientists 

who have conducted fundamental research that has had significant impact in the fields of 

Drug Discovery and Development Interface (DDDI), Formulation Design and Development 

(FDD), and Pharmacokinetics, Pharmacodynamics and Drug Metabolism (PPDM). 

aaps research achievement 

award in drug discovery and 

development Interface 

SPOnSOred by Allergan 

aleem gangjee, ph.d. 

duQueSne univerSity 

Some of the most important strides against 

cancer in the past few years have come from 

combination chemotherapy. However, the 

use of two or more separate agents have 

disadvantages such as pharmacokinetic 

differences of the drugs that may preclude 

the concept of combination chemotherapy, 

cost of two or more drugs and patient 

compliance among others. In an attempt 

to circumvent such drawbacks, Dr. Gangjee 

and co-workers designed, synthesized and 

evaluated single agents with “combination 

chemotherapy” attributes. These single 

agents target cancer cells at two or more 

different sites. The dual and multitargeting 

single agents that Dr. Gangjee and 

co-workers have developed include 

dihydrofolate reductase and thymidylate 

synthase targeting agents; antiangiogenic 

and thymidylate synthase targeting agents; 

antimitotic and antiangiogenic agents; 

P13K, mTOR and purine synthesis inhibitors; 

tumor selective folate transport and purine 

synthesis inhibitors. A number of these 

rationally designed drugs are in preclinical 

development and show remarkable efficacy 

in in vivo animal tumor xenograft models 

and are poised for possible clinical trials. 

22 


Dr. Gangjee will be speaking on Tuesday, 

October 16, from 8:30 am – 11:00 am 

in Room W185 at the McCormick Place 

Convention Center. 

aaps research achievement award in 


SPOnSOred by Pfizer inc. 

mansoor a. Khan, r.ph., ph.d. 

u.S. fOOd And drug AdMiniStrAtiOn 

Dr. Khan is a Senior Biomedical Research 

Scientist (SBRS) and serves as the Director 

of Product Quality Research in the Center 

for Drug Evaluation and Research (CDER) 

in FDA. Prior to joining FDA in 2004, Dr. 

Khan was a Professor of Pharmaceutics 

and Director of Graduate Program in the 

School of Pharmacy at Texas Tech University. 

He earned his Ph.D. in Industrial Pharmacy 

from the St. John’s University School of 

Pharmacy in 1992. He has published over 

210 peer-reviewed manuscripts, four texts, 

15 book chapters, and has been invited to 

give more than 150 presentations worldwide. 

Dr. Khan’s research focuses primarily 

in the area of drug formulations design and 

development of “challenging molecules.” 

It encompasses pediatric dosage forms, 

nanoparticles, modified release dosage 

forms, biosimilar characterization, particulate 

engineering, and scientific underpinnings 

of Quality by Design utilizing novel Process 

Analytical Technologies. As the Director

of Product Quality Research, Dr. Khan 

serves as CDER’s principal advisor on all 

matters related to planning and conducting 

research to study the impact on product 

quality, changes in bulk drug substances, 

formulation component and composition, 

and manu-facturing equipment and 

processes. 

As a recognized expert, Dr. Khan participates 

fully in policy formulation; planning and 

evaluating programs, including oversight 

of pharmaceutical science activities to 

insure that basic and original research are 

considered in major CDER decisions. He 

maintains contact with “state of the science” 

in order to integrate the most advanced 

research theory or practice in the field of 

pharmaceutical science into the Center’s 

new, generic, and biotech drug programs. 

Dr. Khan is an AAPS Fellow, and serves 

on the editorial board of several leading 

journals. 

Dr. Khan will be speaking on Tuesday, 

October 16, from 8:30 am – 12:00 pm 




pharmacokinetics, pharmacodynamics, 

and drug metabolism 

SPOnSOred by Aptalis Pharmaceutical 

technologies 

Jashvant d. unadkat, ph.d. 

univerSity Of wAShingtOn 

Dr. Jashvant (Jash) Unadkat’s laboratory has 

established an international reputation in 

the area of mechanisms of drug transport, 

metabolism and drug interactions (DDI) 

and in the impact of physiological and 

pathological changes on these processes. 

Translating findings from the bench to 

the bedside is a hallmark of his laboratory. 


His laboratory was the first to measure 

P-glycoprotein activity and its inhibition at 

the human blood-brain barrier (BBB) using 

a novel PET imaging technique. Based on 

these studies, it is now widely accepted that 

inadvertent P-gp DDI at the human BBB are 

unlikely to occur except when the drug is 

predominately excluded from the brain by 

P-gp. In addition, his laboratory has found 

that the activity of P-gp at the BBB, which 

transports beta-amyloid out of the brain, is 

compromised in Alzheimer’s disease. This 

finding could result in novel ways to treat 

this disease. Further, Dr. Unadkat’s work has 

the potential to increase the effectiveness 

of drugs in the treatment of diseases such 

as hepatitis C. Specifically, he has found 

that the dosing regimens of ribavirin as it 

is typically used to treat hepatitis C may 

not be optimal because the distribution of 

ribavirin into hepatocytes (the target site) 

is saturated. 

Dr. Unadkat will be speaking on Tuesday, 

October 16, from 8:30 am – 12:00 pm 





aaps regulatory sciences 

achievement award 

SPOnSOred by novartis vaccines and 

diagnostics, inc. 

Vijay Kumar Tammara, ph.d. 

nurOn biOteCh inC. 

Dr. Tammara previously served as a Director, 

Regulatory Affairs at Merck & Co., Inc., Senior 

Associate Director at Wyeth Pharmaceuticals 

and as an Assistant Director at Sanofi- 

Synthelabo in Worldwide Regulatory Affairs. 

Prior to his industrial positions, Dr. Tammara 

held increasingly responsible positions 

in the Office of Clinical Pharmacology 

and Biopharmaceutics at the FDA and 

received several FDA awards including the 

CDER Outstanding Reviewer Award, FDA 

Outstanding Achievement Award, Group 

Recognition Awards, Center Director’s 

Special Citation Awards, CDER Team 

Excellence Awards, Team Spirit Awards, and 

Awards of Excellence. His industrial awards 

include Merck’s Awards of Excellence in 

2004, 2005, 2007, 2009, and 2010 and 

Special Recognition Awards in 2007, 2008, 

2009, and 2010. He is also the recipient of 

the AAPS RS Section Recognition Awards 

in 2004, 2007 and 2008. He also received 

the 2009 Distinguished Scientist Award 

from the American Association of Indian 

Pharmaceutical Scientists. 

24 


dale E. wurster research award 

in pharmaceutics 

SPOnSOred by dale eric and Pamela A. 

wurster/Susan wurster biel 

The purpose of this award is to recognize 

individuals who have made significant 

research contributions to the pharmaceutical 

sciences in the specific field of 

pharmaceutics. 

Bradley d. anderson, ph.d. 


Dr. Anderson focuses on mechanismbased 

predictive relationships linking 

drug molecular structure, speciation, 

and intermolecular interactions to 

pharmaceutically relevant physical 

properties such as solubility and 

solubilization in formulations, chemical 

& physical stability of solutions and 

amorphous solids, and membrane 

transport/drug delivery. His research 

combines experimental studies, molecular 

dynamics computer simulations, and 

mathematical model development 

founded on physical and physical organic 

chemistry to understand and optimize 

drug developability, formulation quality, 

and delivery system performance. Several 

prodrugs or delivery systems designed or 

explored in Dr. Anderson’s laboratories have 

been patented and some have advanced 

to clinical studies or commercialization. 

Biophysical insights and quantitative 

relationships between passive membrane 

transport and structure stemming from his 

investigations of drug permeability across 

lipid bilayer membranes have advanced 

understanding of drug transport across 

biomembrane barriers including the skin, 

oral mucosa, and blood-brain barrier and led 

to the design of lipid-based drug delivery 

systems with tunable drug release kinetics 

for cancer chemotherapy. Recently, he has

contributed to a mechanistic understanding 

of the chemical and physical stability of 

amorphous solid formulations by taking 

into account mobility effects on competing 

pathways governing the fate of reactive 

intermediates during chemical degradation 

and utilizing molecular dynamics computer 

simulations to explore specific drugexcipient 

interactions governing physical 

stability and performance. 

distinguished service award 

SPOnSOred by Sanofi 

The AAPS Distinguished Service Award 

is intended to recognize distinguished 

service in advancing the pharmaceutical 

sciences and the American Association of 

Pharmaceutical Scientists. 

larry l. augsburger, ph.d. 

university of Maryland 

Dr. Augsburger is an internationally 

recognized researcher in pharmaceutics, the 

broad pharmaceutical science community, 

as well as in the fields of process engineering 

and the formulation and control of dietary 

supplements. His research has contributed 

to the basic science underpinning oral solid 

dosage form fabrication and quality, and to 

the practice of manufacture and regulation 

of these products. His research thus deals 

with a highly important aspect of material 

sciences that has direct relevance to public 

health with respect to both drugs and dietary 

supplements. Supported by more than $13.5 

million in grants and contracts from the NIH, 

FDA and private industry, his work has been 

recognized by a number of awards, among 

which are the Federation Internationale 

Pharmaceutique (FIP) Industrial Pharmacy 

Medal, the AAPS Dale E. Wurster Research 

Award in Pharmaceutics, and the Dr. Patricia 


Sokolove Outstanding Mentor Award for 

his work with graduate students. A charter 

member of AAPS, Dr. Augsburger has a 

long and distinguished record of service to 

AAPS and was the 1999 AAPS president. His 

research achievements combined with his 

dedicated service to AAPS have significantly 

and meaningfully advanced both the 

pharmaceutical sciences and the American 

Association of Pharmaceutical Scientists. 


OpEnIng sEssIOn 

IncOmIng prEsIdEnT’s 

rEmarKs 


AAPS PreSident-eleCt 

spEcIal rEcOgnITIOn 

colin m. minchom, ph.d. 

2012 AnnuAl Meeting PrOgrAM ChAir 

Introduction of 2012 annual meeting 

program committee 

Colin M. Minchom, Ph.D. (Chair) 

Christopher R. McCurdy, Ph.D. (Chair-elect) 

Elizabeth de Lange, Ph.D. (2013 Chair-elect) 

Anthony J. DeStefano, Ph.D. (Past Chair) 

Stephen T. Colgan, Ph.D. (APQ Section) 

William Nowatzke, Ph.D. (BIOTEC Section) 

Thaddeus H. Grasela, Pharm. D., Ph.D. 

(CPTR Section) 

Annette Bak, Ph.D., MBA (DDDI Section) 

Lavinia Marina Lewis, Ph.D. (FDD Section) 

Cynthia A. Oksanen, Ph.D. (MSE Section) 

Ping Gao, Ph.D. (PPB Section) 

Joseph W. Polli, Ph.D. (PPDM Section) 

Ganapathy Mohan, Ph.D. (RS Section) 

Russell S. Weiner, Ph.D. (EC Liaison) 

26 


KEYnOTE addrEss 

rebecca skloot 

AuthOr; fOunder And PreSident Of the 

henriettA lACKS fOundAtiOn 

Bestselling author Rebecca Skloot spent 

over ten years doggedly uncovering the 

truth about the life, death, and ultimate 

“immortality” of a poor black tobacco 

farmer named Henrietta Lacks. In The 

Immortal Life of Henrietta Lacks, Skloot 

tells the narrative of a young black 

woman who died of cervical cancer in 

1951—and left behind an inexplicably 

immortal line of cells known as HeLa. 

Henrietta Lacks, whose cells—harvested 

without her knowledge or consent— 

contributed to scientific advancements as 

varied as the polio vaccine, treatments for 

cancers and viruses, in vitro fertilization, 

and the impact of space travel on human 

cells. Part detective story, part scientific 

odyssey, and part family saga, the book’s 

multi-layered approach raises fascinating 

questions about race, class, and bioethics 

in America. 

Though best-known for The Immortal 

Life of Henrietta Lacks, Rebecca Skloot 

has written more than 200 feature 

articles, personal essays, book reviews, 

and news stories for The New York 

Times Magazine; O, The Oprah Magazine; 

Discover; Columbia Journalism Review; 

Seed; New Yorker Magazine; Slate; 

Popular Science; Chicago Tribune; and 

other publications. 

Rebecca Skloot has a B.S. in biological 

sciences and a MFA in creative 

nonfiction. She has taught creative 

writing and science journalism at the 

University of Memphis, the University of 

Pittsburgh, and New York University. She 

is founder and president of the Henrietta 

Lacks Foundation.

InTrOducTIOn Of THE 

2013 aaps ExEcuTIVE cOuncIl 


PreSident 

marilyn E. morris, ph.d. 

PreSident-eleCt 


iMMediAte PASt PreSident 

phillip ramsey, m.B.a., r.a.c. 

treASurer 

James E. polli, ph.d. (2013) 


raman Venkataramanan, ph.d. (2013) 


dannette K. doolittle, ph.d. (2014) 


russell s. weiner, ph.d. (2014) 


Binodh s. desilva, ph.d. (2015) 



aaps awards HIsTOrY 

aaps distinguished pharmaceutical 

scientist award 

1989 Leslie Z. Benet, Ph.D. 

1991 Dale E. Wurster, Ph.D. 

1993 Robert S. Langer, Sc.D. 

1995 George Zografi, Ph.D. 

1997 Ronald T. Borchardt, Ph.D. 

1999 Joseph R. Robinson, Ph.D. 

2001 Wolfgang Sadée, Ph.D. 

2003 Yuichi Sugiyama, Ph.D. 

2005 Gordon L. Amidon, Ph.D. 

2007 Nicholas S. Bodor, Ph.D. 

2009 Michael J. Pikal, Ph.D. 

2011 Valentino J. Stella, Ph.D. 

aaps dale E. wurster research award 


1992 Gerhard Levy, Pharm.D. 

1994 William I. Higuchi, Ph.D. 


1998 Sung Wan Kim, Ph.D. 


2002 Nicholas A. Peppas, Sc.D., D.Eng. 

2004 David J. W. Grant, Ph.D. 

2006 Patrick P. DeLuca, Ph.D. 

2008 Larry Augsburger, Ph.D. 

2010 Theodore W. Randolph, Ph.D. 

2012 Brad Anderson, Ph.D. 

aaps distinguished service award 

1990 Klaus G. Florey, Ph.D. 

1992 Karl A. DeSante, Ph.D. 



1998 Vincent H.L. Lee, Ph.D. 

2000 Vinod P. Shah, Ph.D. 

2002 Jerome P. Skelly, Ph.D. 

2004 Richard F. Bergstrom, Ph.D. 

2006 Mario L. Rocci, Jr., Ph.D. 

2008 Sathyanarayana (Satyam) M. 

Upadrashta, Ph.D., RAC 

2010 Ho-Leung Fung, Ph.D. 

2012 Larry L. Augsburger, Ph.D. 

research achievement award in analysis 

and pharmaceutical Quality 

1988 John C. Craig, Ph.D. 

1990 James T. Stewart, Ph.D. 

1992 Kamal K. Midha, Ph.D. 

1994 William D. Mason, Ph.D. 

1996 H. Thomas Karnes, Ph.D. 

1998 Harry G. Brittain, Ph.D. 

2000 Peter Kissinger, Ph.D. 

2003 Bogdan Matuszewski, Ph.D. 

2004 Susan M. Lunte, Ph.D. 

2006 Mohammed Jemal, Ph.D. 

2008 Craig Lunte, Ph.D. 

2010 Michael G. Bartlett, Ph.D. 

28 


aaps research achievement award 

in Biotechnology 



1997 Mark C. Manning, Ph.D. 

1999 Charles R. Middaugh, Ph.D. 

2001 Francis C. Szoka, Ph.D. 

2003 Victor C. Yang, Ph.D. 

2005 Richard D. DiMarchi, Ph.D. 

2007 John F. Carpenter, Ph.D. 

2009 David Scott, Ph.D. 


clinical pharmacology and Translational 

research (formerly clinical sciences) 

1991 Jerome J. Schentag, Pharm.D. 

1995 Daniel L. Azarnoff, M.D. 

1997 Roger Jelliffe, Ph.D. 

1998 Milap C. Nahata, MS, Pharm.D. 

2004 Hartmut Derendorf, Ph.D. 

2005 David J. Greenblatt, M.D. 

2007 Nick Holford, M.D., M.B., Ch.B. 

2009 Mark J. Ratain, MD 

2011 Jeffrey Barrett, Ph.D., FCP 

aaps research achievement 

award in Economic, marketing and 

management sciences 

1990 Mickey C. Smith, Ph.D. 

1992 Charles D. Hepler, Ph.D. 

1994 Andy S. Stergachis, Ph.D. 

1996 J. Lyle Bootman, Ph.D. 

1998 Jeffrey A. Kotzan, Ph.D. 

2000 Dev S. Pathak, DBA 


drug discovery and development Interface 

(formerly drug design and discovery) 

1988 Nicholas S. Bodor, Ph.D. 

1990 Philip S. Portoghese, Ph.D. 

1992 Daniel H. Rich, Ph.D. 


1996 Ralph F. Hirschmann, Ph.D. 

1998 Kenner C. Rice, Ph.D. 

2000 Peter W. Schiller, Ph.D. 

2002 Alexandros Makriyannis, Ph.D. 

2004 Rao S. Rapaka, Ph.D. 

2006 F. Ivy Carroll, Ph.D. 

2008 Lemont B. Kier, Ph.D. 

2010 Peter A. Crooks, Ph.D. 

2012 Aleem Gangjee, Ph.D. 



2010 Abu T. M. Serajuddin, Ph.D. 

2012 Mansoor A. Khan, R.Ph., Ph.D.


manufacturing science & Engineering 

2009 Dale Eric Wurster, Ph.D. 

2011 Ahmed Adel Sakr, Ph.D. 


pharmaceutics and drug delivery 

1988 William I. Higuchi, Ph.D. 

1989 Armando J. Aguiar, Ph.D. 


1993 Felix Theeuwes, D.Sc. 

1995 Sung Wan Kim, Ph.D. 

1997 Valentino J. Stella, Ph.D. 

1999 Tsuneji Nagai, Ph.D. 

2001 Kinam Park, Ph.D. 

2003 Vincent H.L. Lee, Ph.D. 

2005 Vladimir P. Torchilin, Ph.D. 

2007 Mitsuru Hashida, Ph.D. 

aaps research achievement award 

in pharmacokinetics, pharmacodynamics 


1988 Ho-Leung Fung, Ph.D. 

1990 Edward R. Garrett, Ph.D. 

1992 John G. Wagner, Ph.D. 

1994 Malcolm Rowland, Ph.D. 

1996 Milo Gibaldi, Ph.D. 

1998 William J. Jusko, Ph.D. 

2000 Grant R. Wilkinson, Ph.D. 

2002 K. Sandy Pang, Ph.D. 

2004 Jessie L-S. Au, Ph.D. 

2006 Kathleen Giacomini, Ph.D. 

2008 Ken-ichi Inui, Ph.D. 

2010 Meindert Danhof, Ph.D 

2012 Jashvant D. Unadkat, Ph.D. 


pharmaceutical Technologies 


1989 Ralph F. Shangraw, Ph.D. 

1991 Stanley L. Hem, Ph.D. 

1993 Hans Leuenberger, Ph.D. 

1995 Eugene L. Parrott, Ph.D. 

1997 J. Keith Guillory, Ph.D. 

1999 Nicholas A. Peppas, Sc.D., D.Eng. 

2001 Michael J. Pikal, Ph.D. 

2003 Larry L. Augsburger, Ph.D. 

2005 James W. McGinity, Ph.D. 

2007 Steven L. Nail, Ph.D. 

aaps regulatory sciences 

achievement award 

2004 Jerome P. Skelly, Ph.D. 

2006 Ajaz S. Hussain, Ph.D. 

2008 Moheb M. Nasr, Ph.D. 

2010 Sathyanarayana (Satyam) Upadrashta, 

Ph.D., RAC 

2012 Vijay Tammara, Ph.D. 


aaps lipid-based drug delivery 

Outstanding research award 

2005 Anette Müllertz, Ph.D. 

2006 Russell J. Mumper, Ph.D. 

2007 Kishor M. Wasan, Ph.D. 

2008 Hayat Onyuksel, Ph.D. 

2009 Christopher J.H. Porter, Ph.D. 

2011 Ben Boyd, Ph.D. 

aaps Excellence in ligand Binding assays 

2004 Jason Pennucci 

Steven Swanson, Ph.D. 

Shalini Gupta, Ph.D. 

2005 Lin Yang 

Stephanie Sidobre, Ph.D. 

L. Kelly 

C. Cooper 

M. Khan 

2006 F. Nabbie 

S. Chang 

G. Schieven 

R. Zhang 

J. Kelsey 

R. Weiner 

Y. Barrett 

2007 Joan Kelsey 

2008 Daniel J. Baltrukonis 

Thomas Kawabata 

Deborah Finco-Kent 

2009 Susan Jacques 

Shalini Gupta 

Steve Swanson 

Arunan Kaliyaperumal 

2010 Ray Yin 

Yli Vallejo 

Jing Pan 

Thomas Small 

Dujie Qin 

Dave Chen 

2011 Murli Krishna 

Alexander Kozhich 

Suk Kwok 

Zhen Lou 

Paul Rhyne 

2012 Jay Wustner 

MaryLou Dula 

Shawn Fernando 

Katie Bendas 

Yun Liu 

Danielle Horgan 

Dan Hanrahan 

Megan Kuc 

Dongzhao Chen 

Michael Deitrich 

Estie VanVolkenburgh 

Reannon Holland 

Wolfgang Ebel 

Philip Sass 

Nicholas Niclaides 



aaps meritorious manuscript award 

1990 Bradley D. Anderson, Ph.D. 

Prakash V. Raykar, Ph.D. 

Man-Cheong Fung, Ph.D. 


Kevin R. Smith 

1992 Noboru Yata, Ph.D. 

Toshihiko Toyoda, Ph.D. 

Teruo Murakami, Ph.D. 

Akio Nishiura, Ph.D. 

Yutaka Higashi, Ph.D. 

1994 Philip S. Burton, Ph.D. 

Robert A. Conradi, Ph.D. 

Allen R. Hilgers 

Norman F.H. Ho, Ph.D. 

1995 P.K. Tsai, Ph.D. 

David B. Volkin, Ph.D. 

Jonathan M. Dabora 

Karen C. Thompson, Ph.D. 

Mark W. Bruner 

Jacqueline O. Gress 

Bozena Matuszewska, Ph.D. 

Martina Keogan 

Joseph V. Bondi, Ph.D. 

C. Russell Middaugh, Ph.D. 

1996 Akira Tsuji, Ph.D. 

Tetsuya Terasaki, Ph.D. 

Ikumi Tamai, Ph.D. 

Hitomi Takanaga, Ph.D. 

1997 William M. Pardridge, M.D. 

Young Sook Kang, Ph.D. 

Jody L. Buciak 

Jing Yang 

1998 Manoj M. Nerurkar, Ph.D. 

Philip S. Burton, Ph.D. 

Ronald T. Borchardt, Ph.D. 

1999 Zheng Yang, Ph.D. 

Richard C. Brundage, Ph.D., Pharm.D. 

Rashmi H. Barbhaiya, Ph.D. 

Ronald J. Sawchuk, Ph.D. 

2000 Ahmed El-Tahtawy 

Thomas Tozer, Ph.D. 

Ferrin Harrison 

Larry Lesko, Ph.D. 

Roger Williams, M.D. 

2001 Neville M. Concessio 

Michiel M. Van Oort, Ph.D. 

Michael R. Knowles 

Anthony J. Hickey, Ph.D. 

2002 Cynthia Brimer Cline 

James T. Dalton, Ph.D. 

Zixon Zhu 

John Schuetz, Ph.D. 

Kazuto Yasuda 

Elio Vanin 

Mary V. Relling, Pharm.D. 

Yi Lu 

Erin G. Schuetz 

2003 Wiliam M. Pardridge, M.D. 

Ruben J. Boado 

Ningya Shi 

30 


2004 Duxin Sun 

Hans Lennernäs, Ph.D. 

Lynda S. Welage, Pharm D., FCCP 

Jeffery L. Barnett 

Christopher P. Landowski 

David Foster 

David Fleisher, Ph.D. 

Kyung-Dall Lee, Ph.D. 

Gordon L. Amidon, Ph.D. 

2005 Per Artusson, Ph.D. 

Saeho Chong, Ph.D. 

Rick Morrison, Ph.D. 

Lauri Söderberg 

Jan Taipalensuu 

Staffan Tavelin 

2006 Jennifer Smith 

Edward Wood 

Michael Dornish 

2007 Goldie Kaul 

Mansoor M. Amiji, Ph.D. 

2008 William J. Jusko 

Zhenling Yao 

Debra C. DuBois 

Richard R. Almon 

aaps pharmaceutical research meritorious 

manuscript award (formerly aaps 

meritorious manuscript award) 

2009 Gary M. Pollack, Ph.D. 

John C. Kalvass 

2010 Tetsuya Terasaki 

Junichi Kamiie 

Sumio Ohtsuki 

Ryo Iwase 

Ken Ohmine 

Yuki Katsukura 

Kazunari Yanai 

Yumi Sekine 

Yasuo Uchida 

Shingo Ito 

2011 Par Matsson 

Jenny M. Pedersen 

Ulf Norinder 

Christel A.S. Bergstrom 

Per Artursson 

2012 David E. Alonzo, Ph.D. 

Geoff G.Z. Zhang, Ph.D. 

Deliang Zhou, Ph.D. 

Yi Gao, Ph.D. 

Lynne S. Taylor, Ph.D. 

aaps Outstanding Educator award 



2004 Larry L. Augsburger, Ph.D. 

2006 Joseph B. Schwartz, Ph.D. 

2008 Adel Sakr, Ph.D. 

2010 Raj Suryanarayanan (Sury), Ph.D. 

2012 John L. Neumeyer, Ph.D.

aaps Outstanding manuscript award in 

analysis and pharmaceutical Quality 

1997 Perry A. Hailey, Ph.D. 

Phil Doherty 

Paul Tapsell 

Timothy Oliver 

Paul K. Aldridge 

1998 Keith K. Burton 

Jeremy R. Everett 

Michael J. Newman 

Frank S. Pullen 

Don S. Richards 

Alistair G. Swanson 

1999 Shewan M. Aziz, R.Ph., Ph.D. 

Mustafa Yatin, Ph.D. 

David R Worthen, R.Ph., MS, DRW 

David W. Lipke, Ph.D. 

Peter A. Crooks, Ph.D. 

2000 Sean X. Peng, Ph.D. 

Babul Borah, Ph.D. 

Roy L.M. Dobson, Ph.D. 

Y. Diana Liu, Ph.D. 

Stanislaw Pikul, Ph.D. 

2001 Jacob Bongers, Ph.D. 

John J. Cummings 

Mary Beth Ebert 

M. Marcia Federici, Ph.D. 

Linden Gledhill, Ph.D. 

Dipti Gulati, Ph.D. 

George M. Hilliard, Ph.D. 

Brian H. Jones 

Kwan R. Lee, Ph.D. 

Jacek Mozdzanowski, Ph.D. 

Michael Naimoli 

Sudhir Burman, Ph.D. 

2002 Tim Schenk 

H. Irth 

György Marko-Varga, Ph.D. 

L-E. Edholm 

U.R. Tjaden 

Jan van der Greef 

2003 Dannette Hansen-Doolittle, Ph.D. 

Dennis O. Scott, Ph.D. 

Kenneth W. Otis 

Susan M. Lunte, Ph.D. 

2004 Ute Gerhard, Ph.D. 

Steven Thomas 

Russell Mortishire-Smith 

2005 Eva Lenz, Ph.D. 

Jonathan D. Bright, Ph.D. 

Ian D. Wilson, Ph.D. 

Andrew Hughes, Ph.D. 

Henrik Lindberg, Ph.D. 

Andrew J. Locton, Ph.D. 

2006 Peter L.D. Wildfong 

Nicole A. Morley 

Michael D. Moore 

Kenneth R. Morris, Ph.D. 


2007 Bryan H. Huynh 

Barbara A. Fogarty 

Pradyof Nandi 


2008 Yuerong Hu 

Håkan Wikström 

Stephen R. Byrn 

Lynne S. Taylor 

2009 Kyung H. Gahm 

Helming Tan 

Jodi Liu 

Wesley Barnhart 

John Eschelbach 

Steve Notari 

Samuel Thomas 

David Semin 

Janet Cheetham 

2012 Raj Suryanarayanan, Ph.D. 

Kapildev K. Arora, Ph.D. 

Nitin G. Tayade, Ph.D. 

aaps Outstanding manuscript award 

in PharmSciTech (formerly Outstanding 

manuscript in pharmaceutical development 

and Technology) 

1998 Srinivas S. Duggirala, Ph.D. 

Rahul C. Mehta, Ph.D. 

Patrick P. DeLuca, Ph.D. 

2000 Wei-Qin (Tony)Tong 

Graham Whitsell 

2002 Janusz W. Kostanski, Ph.D. 


2004 Chandra Vemavarapu, Ph.D. 

Matthew J. Mollan, Ph.D. 

Thomas E. Needham, Ph.D. 

2006 Susan D’Souza 

Jabar Faraj, Ph.D. 


2008 Ambikanandan Misra (Lead Author) 

Tushar K. Vyas 

A.K. Babbar 

Rakesh K. Sharma 

Shashi Singh 

2010 Svetlana Lyapustina 

Steven Novick 

David Christopher 

Monisha Dey 

Michael Golden 

Stefan Leiner 

Bruce Wyka 

Hans-Joachim Delzeit 

Chris Novack 

Gregory Larner 



aaps Journal manuscript award (formerly 

aaps PharmSci manuscript award) 

2003 Michael H. Qvist 

Ulla Hoeck 

Bo Kreilgaard, Ph.D. 

Flemming Madsen, Ph.D. 

Lars Hovgaard, Ph.D. 

Sven Frokjaer, Ph.D. 

2005 James D. Andya 

Chung C. Hsu, Ph.D. 

Steven J. Shire, Ph.D. 

2007 Siddhesh D. Patil, Ph.D. 

David G. Rhodes, Ph.D. 

Diane J. Burgess, Ph.D. 

2009 Vladimir P. Torchilin, Ph.D. 

2011 Ayman El-Sayed 

Shiroh Futaki 

Hideyoshi Harashima 

aaps Outstanding manuscript in modeling 

and simulation award 

2008 Kaori Ito 

Matt M Hutmacher 

Jing Liu 

Ruolun Qiu 

Bill Frame 

Raymond Miller 

2009 Dhaval K. Shah 

Beom Soo Shin 

Jean Veith 

Karoly Toth 

Ralph J. Bernacki 

Joseph P. Balthasar 

2010 Eric Snoeck 

Karin Jorga 

Pascal Chanu 

Mark Lavielle 

Philippe Jacqmin 

E Niclas Jonsson 

Timothy Goggin 

Joseph Grippo 

N. L’ntshotshole Shasha Jumbe 

Nicolas Frey 

2012 Paulo Paixão 

José A.G. Morais 

Luís F. Gouveia 

aaps PharmSci & aaps PharmSciTech 

Outstanding use of Technology award 

2003 Keith D. Jensen 

Pavla Kopecková 

John H.B. Bridge 

Jindrich Kopecek 

32 


aaps new Investigator grant in 

pharmaceutics and the pharmaceutical 

Technologies 

1987 Ronald A. Siegel, Sc.D. 

1988 Elizabeth Topp, Ph.D. 

1989 Ashim K. Mitra, Ph.D. 

1990 Anthony J. Hickey, Ph.D. 

1991 Timothy S. Wiedmann, Ph.D. 

1992 Yongyut Rojanasakul, Ph.D. 

1993 Patrick J. Sinko, Ph.D. 

1994 Jane Pei-Fan Bai, Ph.D. 

1995 Paul M. Bummer, Ph.D. 

1996 Susanna Wu-Pong, Ph.D. 

1997 Uday B. Kompella, Ph.D. 

1998 James E. Polli, Ph.D. 

1999 Jeffrey Hughes, Ph.D. 

2000 Peter W. Swaan, Ph.D. 

2001 Kishor M. Wasan, Ph.D. 

2002 Tonglei Li, Ph.D. 

2003 Lynne S. Taylor, Ph.D. 

2004 Abdul W. Basit, Ph.D. 

2005 Christopher J. Roberts 

2006 Karen Hapgood, Ph.D. 

2007 Hugh D. Smyth, Ph.D. 

2008 Changquan (Calvin) Sun, Ph.D. 

2009 Yoon Yeo, Ph.D. 

2010 Jerry Y. Y. Heng, Ph.D. 

2011 Kun Cheng, Ph.D. 

2012 Seungpyo Hong, Ph.D. 

aaps new Investigator grant in 

pharmacokinetics, pharmacodynamics 


1992 Kathleen M. Boje, Ph.D. 

1994 An-Ng (Tony) Kong, Ph.D. 

1996 Deanna L. Kroetz, Ph.D. 

1998 David R. Taft, Ph.D. 

2000 Bernd Meibohm, Ph.D. 

2002 Lane J. Brunner, Ph.D. 

2005 Carolyn A. Fairbanks 

2007 Donald E. Mager, Ph.D. 

2009 Swati V. Nagar 

2011 Patrick Thomas Ronaldson, Ph.D. 

aaps new Investigator grant in Oral 

lipids-based drug delivery systems 

1999 Christopher J. H. Porter, Ph.D. 

2001 Ijeoma F. Uchegbu, Ph.D. 

2002 Xiaochen Gu

aaps postdoctoral fellow 

1999 Sheri L. Shamblin, Ph.D. 

2000 Wolfgang Jacobsen, Ph.D. 

2002 Yurong Lai, Ph.D. 

2003 Ramapuram Jayachandra Babu 

2004 Siddhesh D. Patil, Ph.D. 

2005 Vanessa M. D’Souza 

2006 Mo Yun 

2007 Carolyn Cummins, Ph.D. 

Heidi M. Mansour, Ph.D., R.Ph. 

2008 Udaya Toti, Ph.D. 

2009 Chandrasekar Durairaj, Ph.D. 

Christina Kriegel, Ph.D. 

2010 Bernard Van Eerdenbrugh, Ph.D. 

2011 Limin Shi, Ph.D. 

2012 Courtney Sloan, Ph.D. 

aaps drug delivery Technology award 

2008 John T. Santini, Jr., Ph.D.(Lead 

researcher) 

Elizabeth Proos 

James Prescott, Ph.D. 

aaps dr. rainer Hoffman product Through 

science award 

2008 Gary W. Cleary, Ph.D. 

2009 Eugene R. Cooper, Ph.D. 

2010 Professor Hans E. Junginger, Ph.D. 

2011 Francis C. Szoka, Ph.D. 

lipid-Based drug delivery graduate 

student award 

2008 Annalisa Mercuri 

Caroline Goddeeris 

2009 Mrs. Harisun Yaakob 

2010 Hazem Ali 

Perrine Pivette 

2011 Anne Tungelund Larsen 

2012 Yan Yan Yeap 

Outstanding graduate student research 

award in pT 

2001 Jukka Rantanen 

Sian Tiong Lim 

Bhas A. Dani 

2002 Chandra S. Vemavarapu 

Ge Jiang 

Vasu Venkat Sethuraman 

2003 Niklas Laitinen 

Santos B. Murty 

Yong Qiu 

2004 Stefano Giovagnoli 

Sinjan De 

Yoon Yeo 

2005 Loice Kikwai-Mutua 

Susan D’Souza 

Pankaj P. Dayal 


2006 Jerry Yong Yew Heng 

Preetanshu Pandey 

2007 Robert J. Garmise 

2008 Sabiruddin Mirza 

2009 Maike Windbergs 

2011 Zhe Wang 

2012 Qi (Tony) Zhou 

aaps david J.w. grant research award in 

physical pharmacy 

2009 Stephen R. Byrn, Ph.D. 

2011 Lian Yu, Ph.D. 

Innovation in nanotechnology 

2011 Fu Chen 

2012 Arun Kumar Upadhyay 

Innovation in Biotechnology awards 

2010 Todd Hager 

Hongwei Zhang 

Ajit Sharma 

Annie De Groot 

2011 Kaila Bennett 

Matthew R. Durk 

Diwakar Shukla 

Suzanna Taterewicz 

Chenguang Zhou 

2012 Mark Spengler 

Payal Agarwal 

Sathy V. Balu-Iyer 

Shraddha Thakkar 

Steven Jay 

community service award 


2012 Joseph W. Polli, Ph.D. 



a 

Moji Christianah Adeyeye, Ph.D. 

Akwete Lex Adjei, Ph.D. 

Kevin D. Altria, Ph.D. 

Armando J. Aguiar, Ph.D. 

Michael J. Akers, Ph.D. 

Kenneth S. Albert, Ph.D. 

Sandra R.B. Allerheiligen, Ph.D. 

Gordon L. Amidon, Ph.D. 

Gregory E. Amidon, Ph.D. 

Mansoor M. Amiji, Ph.D. 

Bradley D. Anderson, Ph.D. 

James B. Appino, Ph.D. 

Daniel W. Armstrong, Ph.D. 

Per Artursson, M Sci Pharm, 

Ph.D. 

Okezie I. Aruoma, Ph.D., DSc 

Jessie L-S. Au, Ph.D. 

Kenneth L. Audus, Ph.D. 

Larry L. Augsburger, Ph.D. 

Patrick Augustijns, Ph.D. 

Michael E. Aulton, Ph.D. 

Bruce Aungst, Ph.D. 

Kenneth E. Avis, D.Sc. 

James W. Ayres, Ph.D. 

Daniel L. Azarnoff, M.D. 

B 

You Bae, Ph.D 

Steven W. Baertschi, Ph.D. 

Marcel Bally, Ph.D. 

Joseph P. Balthasar, Ph.D. 

Ajay K. Banga, Ph.D. 

Gilbert S. Banker, Ph.D. 

Rashmi H. Barbhaiya, Ph.D. 

Thomas J. Bardos, Ph.D. 

William H. Barr, Ph.D. 

Jeffrey S. Barrett, Ph.D. 

Brian W. Barry, Ph.D. 

Herbert Barry, III, Ph.D. 

Michael G. Bartlett, Ph.D. 

Theodore R. Bates, Ph.D. 

Vijay K. Batra, Ph.D. 

Charan R. Behl, Ph.D. 

Ihor Bekersky, Ph.D. 

Reina Bendayan, Pharm.D. 

Leslie Z. Benet, Ph.D. 

Simon Benita, Ph.D. 

Terry L. Benney, Ph.D. 

Jean Pierre Benoit, Ph.D. 

Richard F. Bergstrom, Ph.D. 

William F. Beyer 

Meir Bialer, Ph.D. 

John A. Biles, Ph.D. 

Ian A. Blair, Ph.D. 

James Blanchard, Ph.D. 

34 


Lawrence H. Block, Ph.D. 

Robert A. Blouin, Pharm.D. 

Nicholas S. Bodor, Ph.D. 

Judy P. Boehlert, Ph.D. 

Sanford M. Bolton, Ph.D. 

Peter L. Bonate, Ph.D., FCP 

J. Lyle Bootman, Ph.D. 

Ronald T. Borchardt, Ph.D. 

F. Douglas Boudinot, Ph.D. 

Ronald R. Bowsher, Ph.D 

Harold G. Boxenbaum, Ph.D. 

James C. Boylan, Ph.D. 

Douwe D. Breimer, Ph.D. 

Marcus E. Brewster, III, Ph.D. 

Harry G. Brittain, Ph.D. 

Marvin A. Brooks, Ph.D. 

Kim L.R. Brouwer, Ph.D. 

Robert W. Brueggemier, Ph.D. 

Graham Buckton, Ph.D. 

David E. Bugay, Ph.D. 

Hans Bundgaard 

Diane J. Burgess, Ph.D. 

Philip S. Burton, Ph.D. 

Louis Busse, Ph.D. 

Stephen R. Byrn, Ph.D. 

Peter R. Byron, Ph.D. 

c 

Donald E. Cadwallader, Ph.D. 

Henry C. Caldwell, Ph.D. 

Carla M. Caramella, Pharm. D. 

John R. Cardinal, Ph.D. 

David P. Carew, Ph.D. 

John F. Carpenter, Ph.D. 

C. Jelleff Carr, Ph.D. 

Frank I. Carroll, Ph.D. 

Jens T. Carstensen, Ph.D. 

John M. Cassady, Ph.D. 

Lindley A. Cates, Ph.D. 

Mitchell N. Cayen, Ph.D. 

Lester Chafetz, Ph.D. 

Hak-Kim Chan, Ph.D. 

Keith K.H. Chan, Ph.D. 

Kenneth K. Chan, Ph.D. 

William N. Charman, Ph.D. 

Mei-Ling Chen, Ph.D. 

Yie W. Chien, Ph.D. 

Win L. Chiou, Ph.D. 

Zak T. Chowhan, Ph.D. 

Alexander H.C. Chun, Ph.D. 

Alice M. Clark, Ph.D. 

Gary W. Cleary, Ph.D. 

Jeffrey L. Cleland, Ph.D. 

Jordan L. Cohen, Ph.D. 

Wayne A. Colburn, Ph.D. 

Paolo Colombo, Pharm.D. 

Kenneth A. Connors, Ph.D. 

Panayiotis P. Constantinides, 

Ph.D. 

Ubaldo Conte, Pharm.D. 

Chyung S. Cook, Ph.D. 

Stephen J. Coons, Ph.D. 

Geoffrey A. Cordell, Ph.D. 

Raymond E. Counsell, Ph.D. 

Ronald T. Coutts, Ph.D. 

John C. Craig, Ph.D. 

Daan J.A. Crommelin, Ph.D. 

Peter A. Crooks, Ph.D. 

William G. Crouthamel, Ph.D. 

William Curatolo, Ph.D. 

Robert W. Curley, Jr., Ph.D. 

d 

David Z. D’Argenio, Ph.D. 

Richard N. Dalby, Ph.D. 

James T. Dalton, Ph.D. 

Meindert Danhof, Ph.D. 

Alekha K. Dash 

Stanley S. Davis, Ph.D. 


Hartmut Derendorf, Ph.D. 

Karl A. DeSante, Ph.D. 

J. Arthur de Silva, Ph.D. 

Melgardt M. de Villiers, Ph.D. 

George A. Digenis, Ph.D. 

Shrikant V. Dighe, Ph.D. 

Lewis W. Dittert, Ph.D. 

James T. Doluisio, Ph.D. 

Thomas D. Doyle, Ph.D. 

Jennifer B. Dressman, Ph.D. 

Dominique Duchêne, Ph.D. 

Robert N. Duvall, Ph.D. 

E 

Natalie D. Eddington, Ph.D. 

Gertrude B. Elion, M.S. 

William F. Elmquist, Ph.D. 

Laszlo Endrenyi, Ph.D. 

Ene Ette, Ph.D. 

William E. Evans, Pharm.D. 

f 

Stephen J. Farr, Ph.D. 

Reza Fassihi, Ph.D. 

Richard E. Faust, Ph.D. 

Stuart Feldman, Ph.D. 

Edward G. Feldmann, Ph.D. 

Anthony F. Fell, Ph.D. 

Bobbe L. Ferraiolo, Ph.D. 

John W.A. Findlay, Ph.D. 

Kenneth Finger, Ph.D. 

Joseph A. Fix, Ph.D.

Douglas Flanagan, Jr., Ph.D. 

Joseph C. Fleishaker, Ph.D 

Alexander T. Florence, Ph.D., 

D.Sc. 

Klaus G. Florey, Ph.D. 

Gordon L. Flynn, Ph.D. 

Dale E. Fonner, Ph.D. 

Arlington A. Forist, Ph.D. 

William O. Foye, Ph.D. 

Sylvan G. Frank, Ph.D. 

Ho-Leung Fung, Ph.D. 

g 

Jean P. Gagnon, Ph.D. 

Ping Gao, Ph.D. 

Andrea Gazzaniga, Ph.D. 

Hamid Ghandehari, Ph.D. 

Kathleen M. Giacomini, Ph.D. 

Milo Gibaldi, Ph.D. 

Carol A. Gloff, Ph.D. 

Morton E. Goldberg, Ph.D. 

Wayne R. Gombotz, Ph.D. 

Igor Gonda, Ph.D. 

Frank W. Goodhart, Ph.D. 

Jere E. Goyan, Ph.D. 

Lee T. Grady, Ph.D. 

G. Richard Granneman, Ph.D. 

David J. W. Grant, D.Phil. 

Thaddeus Grasela, Pharm.D, 

Ph.D. 

Gregory Gregoriadis, Ph.D. 

Michael J. Groves, Ph.D. 

Gary L. Grunewald, Ph.D. 

J. Keith Guillory, Ph.D. 

Robert Gurny, Ph.D. 

Richard H. Guy, Ph.D. 

H 

Jonathan Hadgraft, D.Sc. 

Michael J. Hageman, Ph.D. 

Jerome A. Halperin, M.S. 

Margareta Hammarlund- 

Udenaes, Ph.D. 

Robert W. Hammel, Ph.D. 

Manabu Hanano, Ph.D. 

Bruno C. Hancock, Ph.D. 

Justin Hanes, Ph.D. 

Mitsuru Hashida, Ph.D. 

William L. Hayton, Ph.D. 

Kenneth R. Heimlich, Ph.D. 

Jorge Heller, Ph.D. 

William M. Heller, Ph.D. 

Stanley L. Hem, Ph.D. 

Jack D. Henion, Ph.D. 

Piet Herdewijn, Ph.D. 

Anthony J. Hickey, Ph.D. 

Everett N. Hiestand, Ph.D. 

Takeru Higuchi, Ph.D. 

William I. Higuchi, Ph.D. 

A. Atilla Hincal, Ph.D. 

Gilbert J. Hite, Ph.D. 

Norman F.H. Ho, Ph.D. 

Rodney J.Y. Ho. Ph.D. 

Stephen W. Hoag, Ph.D. 

Guenther Hochhaus, Ph.D. 

Irwin L. Honigberg, Ph.D. 

Ryohei Hori, Ph.D. 

Zola P. Horovitz, Ph.D. 

Ken-ichi Hosoya, Ph.D. 

Richard A. Houghten, Ph.D. 

Oliver Hu, Ph.D. 

Jin-Ding Huang, Ph.D. 

Leaf Huang, Ph.D. 

Shiew-Mei Huang, Ph.D. 

Charles D. Hufford, Ph.D. 

C. Anthony Hunt, Ph.D. 

Ajaz Hussain, Ph.D. 

Anwar Hussain, Ph.D. 

Munir A. Hussain, Ph.D. 

I 

Lisbeth Illum, Ph.D., D.Sc. 

Ken-ichi Inui, Ph.D. 

J 

Fakhreddin Jamali, Ph.D. 

Bhaskara R. Jasti, Ph.D. 

Michael Jay, Ph.D. 

Roger Jelliffe, Ph.D. 

Mohammed Jemal, Ph.D. 

Lee Jia, Ph.D. 

Jan H.G. Jonkman, Ph.D. 

Robert S. Joslin, Ph.D. 

Hans E. Junginger, Ph.D. 

William J. Jusko, Ph.D. 

K 

Peter F. Kador 

James J. Kaminski, Ph.D. 

Isadore Kanfer, Ph.D. 

Stanley A. Kaplan, Ph.D. 

Aziz Karim, Ph.D. 

Howard T. Karnes, Ph.D. 

Martin Katz, Ph.D. 

Yoshiaki Kawashima, Ph.D. 

Ian W. Kellaway, D.Sc. 

Richard A. Kenley, Ph.D. 

Mansoor A. Khan, Ph.D. 

Lemont B. Kier, Ph.D. 

Dane O. Kildsig, Ph.D. 

Peter Kleinebudde, Ph.D. 


Chong-Kook Kim, Ph.D. 

Richard B. Kim, M.D. 

Sung W. Kim, Ph.D. 

A. Douglas Kinghorn, Ph.D. 

Arlyn W. Kinkel, Ph.D. 

William J. Kinnard, Ph.D. 

Peter T. Kissinger, Ph.D. 

David A. Knapp, Ph.D. 

Joseph E. Knapp, Ph.D. 

Adelbert M. Knevel, Ph.D. 

Edwin L. Knoechel, Ph.D 

Bozena (Bo) Michniak-Kohn, 

Ph.D. 

Ah-Ng Kong, Ph.D. 

Uday Kompella, Ph.D. 

Jindrich Kopecek, Ph.D. 

Harry B. Kostenbauder, Ph.D. 

Jeffrey Kotzan, Ph.D. 

Jorg W.R. Kreuter, Ph.D. 

Rajesh Krishna, Ph.D., FCP 

Patricia D. Kroboth, Ph.D. 

Deanna Kroetz, Ph.D. 

Roy Kuramoto, Ph.D. 

King Chiu Kwan, Ph.D. 

Glen S. Kwon, Ph.D. 

l 

Vinod Labhasetwar, Ph.D. 

Leon Lachman, Ph.D. 

Richard L. LaLonde, Pharm.D. 

Robert S. Langer, Sc.D. 

Peter R. Langguth, Ph.D. 

Andrew Lasslo, Ph.D. 

Thomas P. Layloff, Ph.D. 

Jean W. Lee, Ph.D. 

Kang Choon Lee, Ph.D. 

Vincent H.L. Lee, Ph.D. 

Kuo-Hsiung Lee, Ph.D. 

Lewis J. Leeson, Ph.D. 

Claus-Michael Lehr, Ph.D. 

August P. Lemberger, Ph.D. 

Hans Lennernäs, Ph.D. 

Lawrence J. Lesko, Ph.D. 

Hans Leuenberger, Ph.D. 

Ralph S. Levi, Ph.D. 

Gerhard Levy, Pharm.D. 

Rene H. Levy, Ph.D. 

Xiaoling Li, Ph.D. 

Jiunn Huei Lin, Ph.D. 

Thorsteinn Loftsson, Ph.D. 

Ti Li Loo, D.Sc. 

Nicholas G. Lordi, Ph.D. 

Ole J. Lorenzetti, Ph.D. 

Donghao Robert Lu, Ph.D. 

Thomas M. Ludden, Ph.D. 

Craig Lunte, Ph.D. 




Louis A. Luzzi, Ph.D. 

m 

Thomas J. Macek, Ph.D. 

Panos E. Macheras, Ph.D. 

Ram I. Mahato, Ph.D. 

Alexandros Makriyannis, Ph.D. 

A. Waseem Malick, Ph.D. 

Louis Malspeis, Ph.D. 

Tarun K. Mandal, Ph.D. 

Mark C. Manning, Ph.D. 

Arnold D. Marcus, Ph.D. 

Keith Marshall, Ph.D. 

Tobias Massa, Ph.D. 

Bogdan K. Matuszewski, Ph.D. 

Michael Mayersohn, Ph.D. 

William F. McGhan, Ph.D. 

Iain J. McGilveray, Ph.D. 

James W. McGinity, Ph.D. 

Gordon McKay, Ph.D. 

Jerry L. McLaughlin, Ph.D. 

Patrick J. McNamara, Ph.D. 

Thomas Medwick, Ph.D. 

Mehul U. Mehta, Ph.D. 

Bernd Meibohm, Ph.D. 

Srikumaran K. Melethil, Ph.D., 

J.D. 

Hans Peter Merkle, Ph.D. 

Carl M. Metzler, Ph.D. 

Marvin C. Meyer, Ph.D. 

C. Russell Middaugh, Ph.D. 

Kamal K. Midha, D.Sc. 

Duane D. Miller, Ph.D. 

Raymond Miller, D.Sc. 

Tamara Minko, Ph.D. 

Hyman Mitchner, Ph.D. 

Ashim K. Mitra, Ph.D. 

Tom S. Miya, Ph.D. 

Arthur R. Mlodozeniec, Ph.D. 

Marilyn M. Martinez, Ph.D. 

Henry I. Mosberg 

Anthony C. Moffat, Ph.D. 

Joyce J. Mordenti, Ph.D. 

Kenneth R. Morris, Ph.D. 

Marilyn E. Morris, Ph.D. 

Daniel Mufson, Ph.D. 

Pasupati Mukerjee, Ph.D. 

Russell J. Mumper, Ph.D. 

Eric J. Munson, Ph.D. 

Ram B. Murty, Ph.D. 

36 


n 

Tsuneji Nagai, Ph.D. 

Steven L. Nail, Ph.D. 

Masahiro Nakano, Ph.D. 

Moheb M. Nasr, Ph.D. 

Kenneth G. Nelson, Ph.D. 

Wendel L. Nelson, Ph.D. 

John L. Neumeyer, Ph.D. 

Tue H. Nguyen, Ph.D. 

David E. Nichols, Ph.D. 

G. Joseph Norwood, Ph.D. 

Robert E. Notari, Ph.D. 

O 

Derek T. O’Hagan, Ph.D. 

Bernard A. Olsen, Ph.D. 

Hayat Onyuksel, Ph.D. 

Masaki Otagiri, Ph.D. 

p 

Kim-Ching (Sandy) Pang, Ph.D. 

Gerald J. Papariello, Ph.D. 

Kinam Park, Ph.D. 

Eugene L. Parrott, Ph.D. 

Dev S. Pathak, D.B.A. 

Thomas F. Patton, Ph.D. 

Rodney Pearlman, Ph.D. 

Carl C. Peck, M.D. 

Garnet E. Peck, Ph.D. 

Nicholas A. Peppas, Sc.D. 

Bengt-Arne Persson, Ph.D. 

Claude Piantadosi, Ph.D. 

Henry J. Pieniaszek, Jr., Ph.D. 

Michael J. Pikal, Ph.D. 

Ian H. Pitman, Ph.D. 

Fridrun Podczeck, Dr. sc. nat. 

habil. 

Gary M. Pollack, Ph.D. 

James E. Polli, Ph.D. 

Joseph W. Polli, Ph.D 

John W. Poole, Ph.D. 

Emil Pop, Ph.D. 

David G. Pope, Ph.D. 

Philip S. Portoghese, Ph.D. 

Russell O. Potts, Ph.D. 

Boyd J. Poulsen, Ph.D. 

Colin W. Pouton, Ph.D. 

J. Robert Powell, Ph.D. 

Michael F. Powell, Ph.D. 

Vadlamani K. Prasad, Ph.D. 

Thomayant Prueksaritanont, 

Ph.D. 

William P. Purcell, Ph.D. 

Q 

Yihong Qiu, Ph.D. 

r 

Galen W. Radebaugh, Ph.D. 

Yueh-Erh Rahman, M.D. 

Theodore Randolph, Ph.D. 

Rao S. Rapaka, Ph.D. 

Louis J. Ravin, Ph.D. 

Indra K. Reddy, Ph.D. 

Robert A. Reed, Ph.D. 

Gurvinder Singh Rekhi, Ph.D. 

Jean Paul Remon, Ph.D. 

Michael A. Repka, Ph.D. 

A.J. Repta, Ph.D. 

Richard H. Reuning, Ph.D. 

Christopher T. Rhodes, Ph.D. 

Kenner C. Rice, Ph.D. 

Christopher M. Riley, Ph.D. 

Edward G. Rippie, Ph.D. 

Wolfgang A. Ritschel, M.D., 

Ph.D. 

Joseph R. Robinson, Ph.D. 

Christopher A. Rodowskas 

A. David Rodrigues, Ph.D. 

Yongyut Rojanasakul, Ph.D 

Alain Rolland, Ph.D. 

Theodore J. Roseman, Ph.D. 

Amy Rosenberg, M.D. 

Carlo Rossi, Pharm.D. 

Malcolm Rowland, Ph.D. 

Frans G.M. Russel, Ph.D. 

Emanuel J. Russo, Ph.D. 

Charles O. Rutledge, Ph.D. 

J. Howard Rytting, Ph.D. 

s 

Mandip S. Sachdeva, Ph.D. 

Wolfgang Sadée, Ph.D. 

A. Adel Sakr, Ph.D. 

Lynda M. Sanders, Ph.D. 

Ronald J. Sawchuk, Ph.D. 

Jerome J. Schentag, Pharm.D. 

Jean-Michel G. Scherrmann, 

Pharm.D., Ph.D. 

Paul L. Schiff, Jr., Ph.D. 

Peter Wilhelm Schiller, Ph.D. 

George Schneller, Ph.D. 

Christian Schöneich, Ph.D. 

Joseph B. Schwartz, Ph.D. 

Michael A. Schwartz, Ph.D. 

John J. Sciarra, Ph.D. 

James A. Seitz, Ph.D. 

Bernard Z. Senkowski, Ph.D.

Cosette J. Serabjit-Singh, Ph.D. 

Abu Serajuddin, Ph.D. 

Hitoshi Sezaki, Ph.D. 

Ashok C. Shah, Ph.D. 

Navnit H. Shah, Ph.D. 

Vinod P. Shah, Ph.D. 

Evgenyi Shalaev, Ph.D. 

Jane E. Shaw, Ph.D. 

Eli Shefter, Ph.D. 

Eric B. Sheinin, Ph.D. 

John W. Shell, Ph.D. 

Danny D. Shen, Ph.D. 

Wei-Chiang Shen, Ph.D. 

Chang-Koo Shim, Ph.D. 

Steven J. Shire, Ph.D. 

Teruna Siahaan, Ph.D. 

Ronald A. Siegel, Sc.D. 

Jeffrey A. Silverman, Ph.D. 

Anthony P. Simonelli, Ph.D. 

Jagdish Singh, Ph.D. 

Manmohan Singh, Ph.D. 

Sampat M. Singhvi, Ph.D. 

Patrick J. Sinko, Ph.D. 

Anthony A. Sinkula, Ph.D. 

John A. Sjögren, Ph.D. 

Jerome P. Skelly, Ph.D. 

John T. Slattery, Ph.D. 

David E. Smith, Ph.D. 

Edward Smith, Ph.D. 

Mickey C. Smith, Ph.D. 

Philip L. Smith, Ph.D. 

Randall B. Smith, Ph.D. 

Quentin Smith, Ph.D. 

Robert V. Smith, Ph.D. 

Theodore D. Sokoloski, Ph.D. 

Albert H. Soloway, Ph.D. 

Marilyn K. Speedie, Ph.D. 

John Staniforth, Ph.D. 

Salomon A. Stavchansky, Ph.D. 

Valentino J. Stella, Ph.D. 

Larry A. Sternson, Ph.D. 

James T. Stewart, Ph.D. 

Clinton Fields Stewart, 

Pharm.D. 

Audra Stinchcomb, Ph.D. 

John F. Stobaugh, Ph.D. 

Robert M. Straubinger, Ph.D. 

Heinz B. Sucker, Ph.D. 

Yuichi Sugiyama, Ph.D. 

Raj Suryanaryanan, Ph.D. 

Steven C. Sutton, Ph.D. 

Hiroshi Suzuki, Ph.D. 

Craig K. Svensson, Ph.D. 

Peter W. Swaan, Ph.D. 

Steven J. Swanson, Ph.D. 

James Swarbrick, Ph.D. 

Joseph V. Swintosky, Ph.D. 

Francis C. Szoka, Jr., Ph.D. 

T 

Yoshinobu Takakura, Ph.D. 

Vijay K. Tamarra, Ph.D. 

Diane D-S. Tang-Liu, Ph.D. 

Rashad Tawashi, Ph.D. 

Lynne S. Taylor, Ph.D. 

David H. Tedeschi, Ph.D. 

Tetsuya Terasaki, Ph.D. 

Bernard J. Testa, Ph.D. 

Dhiren R. Thakker, Ph.D. 

Felix Theeuwes, Ph.D. 

Gary A. Thompson, Ph.D. 

Kenneth E. Thummel, Ph.D. 

Alice E. Till, Ph.D. 

William J. Tillman, Ph.D. 

James E. Tingstad, Ph.D. 

Eric Tomlinson, Ph.D. 

Elizabeth M. Topp, Ph.D. 

Vladimir P. Torchilin, Ph.D., 

D.Sc. 

Thomas N. Tozer, Ph.D. 

Timothy S. Tracy, Ph.D. 

Francis L.S. Tse, Ph.D. 

Akira Tsuji, Ph.D. 

Varro E. Tyler, Ph.D. 

u 

Kaneto Uekama, Ph.D. 

Jashvant D. Unadkat, Ph.D. 

Sathyanarayana M. 

Upadrashta, Ph.D. 

John Urquhart, M.D. 

Arto O. Urtti, Ph.D. 

V 

Elizabeth B. Vadas, Ph.D. 

Glen A. Van Buskirk, Ph.D. 

Peter Veng-Pedersen, Ph.D. 

Jurgen Venitz, Ph.D. 

Raman Venkataramanan, Ph.D. 

S. Jorgen Vessman, Pharm.D., 

Ph.D. 

Paolo Vicini, Ph.D. 

C. T. Viswanathan, Ph.D. 

w 

John A. Wagner, M.D., Ph.D 

John G. Wagner, Ph.D. 

Irving W. Wainer, Ph.D. 

Walter D. Walkling, Ph.D. 


Jesse W. Wallace 

Y. John Wang, Ph.D. 

Kishor M. Wasan, Ph.D. 

Kenneth Waterman, Ph.D. 

Lawrence C. Weaver, Ph.D. 

Jeffry G. Weers, Ph.D. 

Norman D. Weiner, Ph.D. 

Peter G. Welling, Ph.D. 

Albert I. Wertheimer, Ph.D. 

Joseph Wiederholt, Ph.D. 

M. Guillaume Wientjes, Ph.D. 

Grant R. Wilkinson, Ph.D. 

Roger L. Williams, M.D. 

Robert O. Williams, Ph.D. 

Robert J. Wills, Ph.D. 

Donald T. Witiak, Ph.D. 

Manfred E. Wolff, Ph.D. 

Hal N. Wolkoff, Ph.D. 

John H. Wood, Ph.D. 

Paul E. Wray, Ph.D. 

George Wright, Ph.D. 

Dale E. Wurster, Ph.D. 

Dale Eric Wurster, Ph.D. 

Y 

Avraham Yacobi, Ph.D. 

Gerald J. Yakatan, Ph.D. 

Samuel H. Yalkowsky, Ph.D. 

Shinji Yamashita, Ph.D. 

Victor C. Yang, Ph.D. 

Peter York, Ph.D. 

Sumie Yoshioka, Ph.D. 

Lawrence X. Yu, Ph.D. 

Lian Yu, Ph.D. 

Su Il Yum, Ph.D. 

Z 

Alejandro A. Zaffaroni, Ph.D. 

Gaylen M. Zentner, Ph.D. 

Geoff G.Z. Zhang, Ph.D. 

Chang-Guo Zhan, Ph.D. 

Cheryl L. Zimmerman, Ph.D. 

George Zografi, Ph.D. 


38 

Awards Program

2012 aaps annual meeting and Exposition - American Association of ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?